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1 Abstract 
The median age of our population causes osteoporosis, bone fractures and disorders, which 
are also caused by multiple myeloma. In the past 25 years, regenerative medicine had gained 
in importance, especially for regeneration and renewal of bone tissue, which consists of 
different cell types composed in a very complex architecture. The growth factor bone 
morphogenetic protein 6 (BMP-6) belongs to the transforming growth factor β (TGF- β) 
superfamily and it induces the differentiation of mesenchymal stem cells into mature 
osteoblasts in bone leading to new bone formation. Besides induction of osteogenic 
differentiation, BMP-6 is also known to induce cell death in multiple myeloma cells in high 
concentrations. However, a systemic application is not practicable, since uncontrolled 
diffusion causes a wide range of side-effects. Immobilization of growth factors allows local 
treatment of bone fractures and defects, while it prevents uncontrolled release of growth 
factors. Furthermore, the required amount of growth factors can be reduced tremendously. 
The objective of this work was the covalent immobilization of BMP-6 co-presented with 
clicked integrin ligands on a structured gold nanoparticle (AuNP) platform, using block-
copolymer micellar nanolithography (BCMN) developed by Prof. Spatz and co-workers, to 
study integrin signaling in connection with growth factor responses. BMP-6 was selectively 
bound to gold nanoparticles organized in a hexagonal structure on the surface allowing to 
control the amount and density on the surface. I showed that surface co-presentation of BMP-
6 and RGD or α5β1 integrin selective ligand promotes SMAD1/5 phosphorylation and 
osteogenic differentiation of the standard model system C2C12, even at amounts as low as 
1 ng, whereas soluble BMP-6 application is significantly less effective. Additionally, BMP-
6 was immobilized on gold nanostructured polyethylene glycol diacrylamide (PEG-DA) 
hydrogels containing different concentrations of cRGD in order to study the influence of the 
stiffness on the cell signaling. Furthermore, this approach was used to investigate the effect 
of immobilized BMP-6 in low doses on the multiple myeloma cell line OPM-2 to induce 
cell death.   
This approach provides for the first time the successful presentation of BMP-6 in small and 
defined amounts on surfaces in combination with adhesive ligands. Furthermore, covalent 
immobilization hinders protein release while maintaining the biological activity of the 
growth factor. 
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2 Zusammenfassung 
Das durchschnittliche Alter unsere Bevölkerung verursacht Osteoporose, Knochenfrakturen 
und -fehlbildungen, welche auch durch das Multiple Myelom verursacht werden. In den 
vergangenen 25 Jahren hat die regenerative Medizin an Bedeutung gewonnen, insbesondere 
für die Regeneration und die Erneuerung von Knochengewebe, welches sich aus 
verschiedenen Zelltypen in einer sehr komplexen Struktur zusammensetzt. Der 
Wachstumsfaktor Bone Morphogenetic Protein 6 (BMP-6, knochenmorphogenetisches 
Protein 6) gehört zu der transformierenden Wachstumsfaktoren β (Transforming Growth 
Factor β, TGF-β) Superfamilie, und es initiiert die Differenzierung von mesenchymalen 
Stammzellen in reife Osteoblasten, was zur Knochenneubildung führt. Neben der Initiierung 
der osteogenen Differenzierung ist BMP-6 auch bekannt dafür, dass es in hohen 
Konzentrationen den Zelltod in multiplen Myelomzellen herbeiführt. Eine systemische 
Behandlung ist jedoch nicht praktikabel, da eine unkontrollierte Diffusion eine Reihe von 
Nebenwirkungen verursacht. Die Immobilisierung von Wachstumsfaktoren erlaubt die 
lokale Behandlung von Knochenfrakturen und –defekten, während sie auch die 
unkontrollierte Freisetzung von Wachstumsfaktoren verhindert. Des Weiteren kann die 
benötigte Menge an Wachstumsfaktoren drastisch verringert werden. 
Das Ziel dieser Arbeit war die kovalente Immobilisierung von BMP-6 auf einer 
goldnanostrukturierten Plattform, unter Verwendung von block-copolymer micellar 
nanolithography (BCMN) entwickelt von Prof. Spatz und Mitarbeitern, zusammen mit 
integrinselektiven Liganden, was die Erforschung von Integrinsignalisierung in Verbindung 
mit Reaktionen auf Wachstumsfaktoren ermöglicht. BMP-6 wurde selektiv an 
Goldnanopartikel gebunden, welche auf der Oberfläche hexagonal organisiert sind. Dies 
ermöglicht es, die Menge und die Dichte auf der Oberfläche zu kontrollieren. Ich konnte 
zeigen, dass die Oberflächencopräsentation von BMP-6 und cRGD bzw. dem α5β1 Integrin 
selektiven Liganden in Mengen von weniger als 1 ng die SMAD 1/5 Phosphorylierung und 
die osteogenen Differenzierung in dem Standardmodellsystem C2C12 fördert, während das 
gelöste BMP-6 signifikant weniger effektiv war. Um den Einfluss der Steifigkeit auf die 
Zellsignalisierung zu untersuchen, wurde BMP-6 auf Polyethylenglykoldiacrylamid (PEG-
DA) Hydrogele mit einer goldnanostrukturierten Oberfläche und cRGD in verschiedenen 
Konzentrationen immobilisiert. Darüber hinaus wurde dieses Konzept für die Untersuchung 
2 Zusammenfassung 
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des Effekts von gering dosierten, immobilisierten BMP-6 auf die multiple Myelom Zelllinie 
OPM-2 eingesetzt mit der Absicht den Zelltod zu initiieren. 
Dieses System ermöglicht zum ersten Mal die erfolgreiche Präsentation von BMP-6 auf 
Oberflächen in kleinen und definierten Mengen in Kombination mit adhäsiven Liganden. 
Des Weiteren verhindert die kovalente Immobilisierung eine Proteinfreisetzung, während 
die biologische Aktivität des Wachstumsfaktors erhalten bleibt. 
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3 Introduction 
3.1 Bone and Growth factors 
Growth factors (GFs) are a large family of polypeptidic molecules, which stimulate and 
modulate cell responses such as proliferation, differentiation, migration, cell adhesion, cell 
survival and chemotaxis (see Figure 3.1). GFs can be found in all tissues1-3. Naturally 
secreted from cells, many GFs directly interact with the surrounding extra cellular matrix 
(ECM). Furthermore, they can also be sequestered by the ECM in order to interact with cell 
surface receptors in a specific binding4-5.  
 
  
 
Figure 3.1 The path of growth factors in cell signaling from the biosynthesis to the different interactions 
with the ECM. Growth factors are synthesized in the cell and released into the ECM, where they interact with 
different components followed by binding and activating cell receptors. Growth factors form complexes with 
their cognate receptors. Adapted and modified from Mitchell et al.6 
 
The native protein form of growth factors used in regenerative medicine causes limitations 
and properties such as low stability, short circulating half-time and rapid rate of cellular 
internalization. Moreover, their activity is locally restricted in tissue as a function control by 
spatial and temporal effects6-7. The fibroblast growth factor (FGF-1), for example, displays 
its low stability in an effective half-life of only 1 h in serum at 37 °C8. General problems in 
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handling and medical usage of growth factors in research are reflected by the poor 
recombinant expression yield, difficulty of purification, high production costs, high required 
concentration and lack of appropriate delivery methods9. By developing delivery systems 
many of the above-mentioned challenges can be circumvented. 
A plethora of cellular signaling events like organism development, angiogenesis, wound 
healing and regeneration as well as generation of new tissue are mediated by GFs3, 10-11.  
 
3.1.1 Bone morphogenetic proteins 
It’s well-known that different growth factors are involved in the process of bone formation 
by stimulating pre-osteoblasts’ proliferation12. Bone morphogenetic proteins (BMPs) 
comprise a family of growth factors, which possess chemotactic, mitogenic, osteogenic and 
differentiating properties thus playing an important role in bone formation13. In 1965, 
Marshal R. Urist showed that formation of new bone could be induced by implanting 
demineralized, lyophilized segments of bone into ectopic sites14. In 1971, Urist and Strates 
proposed the name “Bone Morphogenetic Protein”15. One year later, it could be shown that 
also demineralized bone matrix was able to induce bone formation in ectopic sites16. In the 
beginning, BMPs were isolated from bone, which was a cumbersome procedure and the 
yield was very low17. BMPs are glycosylated and extracellular matrix-associated molecules, 
that are members of the Transforming Growth Factor Beta (TGF-β) superfamily18-19. In 
general, this type of growth factors is a hetero- or homodimer consisting of about 120 amino 
acids per subunit. Seven of the 120 amino acids are conserved cysteine residues, six of these 
forming intramolecular disulfide bonds creating a knot motif. The other stabilizes the dimer 
through an intermolecular disulfide bridge20-21. By today, about 20 different human BMPs 
including the growth differentiation factors (GDF) have been found, which can be divided 
into subfamilies based on their sequence similarity and functions, whereby not all members 
are osteogenic13. Besides BMP-3 and BMP-13, which act either as a BMP negative regulator 
or as an inhibitor of bone formation, all BMPs are mainly involved in bone and cartilage 
formation22. In Table 3.1 the most investigated and known BMPs are listed. 
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Table 3.1 Overview of BMP family members23. BMP types are listed with their alternative names and their 
functions in human body. 
BMP type Alternative 
name 
Function 
BMP-1 - Metalloprotease acting on procollagen I, II and III, 
involved in cartilage development. 
BMP-2 BMP-2a Bone and cartilage formation, key role in osteoblast 
differentiation. 
BMP-4 BMP-2b Regulation of teeth, limbs and bone formation. 
BMP-5 - Cartilage development. 
BMP-6 Vgr-1; Dvr-6 Key role in joint integrity, bone morphogenesis, 
estrogen mediation. 
BMP-7 OP-1 key role in osteoblast differentiation and in renal 
development and repair. 
BMP-8 OP-2 Involved in bone and cartilage development. 
BMP-9 GDF-2 Promoting chondrogenic differentiation of human 
multipotent mesenchymal stem cells. 
BMP-10 - Role in the trabeculation of the embryonic heart. 
 
Interestingly, BMP-1 belongs neither to the BMP family nor to the TGF-β superfamily, 
although it is called a bone morphogenetic protein. It is a metalloprotease, which is able to 
induce cartilage formation in vivo and cleave the C-terminus of procollagen I, II and III24. In 
2005, Hari Reddi suggested to change BMPs’ name to body morphogenetic proteins, 
because of their effective range, which is not limited to the bone, but plays also an important 
role in the whole body25. 
 
3.1.2 Bone/body morphogenetic protein 6 (BMP-6) 
In 1989, BMP-6 was isolated from murine embryonic cDNA library. Because of its 
homology to Xenopus Vg-1, it received the name Vgr-126. Celeste et al.27 isolated Vgr-1 from 
human and bovine bone and named it BMP-6. The successful expression of the BMP-6 
mRNA in mammals could be shown in different cell types. BMP-6 is produced by bone 
3 Introduction 
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marrow-mesenchymal (BMSC) and hematopoietic stem cells28. Furthermore, BMP-6 is a 
homodimer with the 2 monomers connected through a disulfide bond. In Figure 3.2, the 
three-dimensional structure of the BMP-6 homodimer is presented. The fact, that the protein 
consists of two monomers can be used to develop heterodimers by co-expression of two 
different recombinant BMP subunits. Valera et al.29 engineered a heterodimer consisting of 
BMP-2 and BMP-6 and showed that it was more effective than BMP-2 or BMP-6 
homodimers as an inductor of differentiation in human embryonic stem cells (ES). 
 
 
 
Figure 3.2 The three-dimensional structure of BMP-6 homodimer. BMP-6 consists of two monomers A 
(green) and B (blue). The C- and N-terminus of each BMP-6 monomer are indicated with C and N, respectively. 
Adapted and modified from Saremba et al.30 
 
SMAD proteins are a group of intracellular proteins, which are involved in cell signaling 
processes induced by extracellular growth factors of the TGF-β superfamily. The name 
SMAD originates from the homological gene of the fruit fly Drosophila melanogaster MAD 
(mother against decapentaplegic) and from the protein gene Sma (small body size) of the 
nematode Caenorhabditis elegans31.  
Ebisawa et al.32 showed that BMP-6 strongly binds to activin receptor-like kinase (ALK)-2, 
which is also known as ActR-I, as well as to type II receptors, i.e. BMP type II receptor 
(BMPR-II) and activin type II receptor (ActR-II) C2C12 cells. Additionally, a similarity 
between BMP-6 and BMP-2 is the weak bond to BMPR-IA (ALK-3). Moreover, they 
detected the binding of BMP-6 to BMPR-IB (ALK-6) in ROB-C26 cells, mesenchymal 
progenitor cell line. BMP-6 binds extracellularly, but SMAD proteins are phosphorylated 
intracellularly. 
It is known that BMP-6 induces the phosphorylation of the receptor-regulated SMADs (R-
SMAD, SMAD1, SMAD5 and SMAD8)32 by binding to ActR-II and ActR-I (Figure 3.3). 
 3 Introduction 
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After phosphorylation, R-SMADs are released from the BMP receptor and form a complex 
with the common mediator SMAD (Co-SMAD, SMAD4). Nucleocytoplasmic shuttling of 
the SMAD complex activates transcription of target 28. Sieber et al.33 showed that BMPs are 
also capable to induce gene transcription independent of SMAD molecules. However, there 
are only rudimental investigations about BMP-6 induced signaling pathways beside the 
SMAD dependent pathways. Furthermore, BMP signaling is rather complex with cross-talks 
between different signaling pathways and negative feedback mechanisms34-36. 
 
 
 
Figure 3.3 Induction SMAD 1,5,8 phosphorylation by BMP-6. BMP-6 shows a high affinity to ActR-I and 
ActR-II receptors, which activates SMAD phosphorylation. SMAD complex acts as transcription factor. 
Adapted and modified from Vukicevic et al.28 
 
Induction of osteogenic differentiation 
Osteogenic differentiation is the process of bone development, which is known to be induced 
by BMPs37-39. C2C12 is an immortalized mouse myoblastoma cell line and a standard model 
system used to study the differentiation of myoblasts, osteoblasts, and myogenesis.  
3 Introduction 
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Figure 3.4 BMP-2 SMAD and non-SMAD signaling pathway. A) Signaling via BMP-induced signaling 
complex (BISC). The non-SMAD pathway is activated by BPM-2 binding to its high affinity type I receptor 
(BRI). Then Type II receptor (BRII) is recruiting into the complex of BMP-2 and BRI. B) Signaling via 
preformed complex (PFC). The SMAD pathway is activated by binding of BMP-2 to a PFC of type I and type 
II receptor. Adapted and modified from Sieber et al.33  
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C2C12 cells are undifferentiated mesenchymal cells which differentiate into osteoblasts 
upon stimulation by BMPs. Ebisawa et al.32 published that recombinant human BMP-6 
induces alkaline phosphatase (ALP) activity in C2C12 cells, which is a typical osteoblastic 
marker. ALPs are enzymes which are able to hydrolyze phosphate ester of different 
molecules, such as proteins, nucleotides and alkaloids. BMP-2 is also known to induce ALP 
activity via the non-SMAD pathway by BMP-induced signaling complex (BISC) (see 
Figure 3.4)33. It is assumed that BMP-6 induces the ALP activity in a similar way, although 
it has not been investigated so far. Moreover, the ALP activity induced by BMP-6 was 10-
fold higher than of BMP-7. Similar to BMP-239 and BMP-740, BMP-6 inhibits the myoblastic 
differentiation of C2C12 cells and induces osteoblastic differentiation. BMP-2, BMP-6 and 
BMP-9 are known to be the most potent inducers of osteoblastic differentiation in 
mesenchymal stem cells (MSCs)41-43. However, Mizrahi et al.44 showed that BMP-6 seems 
to induce bone formation in genetically modified MSCs more efficiently than BMP-2. 
Furthermore, they proposed the preferred use of BMP-6 instead of BMP-2, since BMP-2 
had been shown to cause adverse side-effects. 
 
BMP-6 effect on multiple myeloma 
The multiple myeloma is a malignant disease of the hematopoietic system which causes the 
ongoing monoclonal production of antibody-producing cells, namely plasma cells45. B-
lymphocytes normally differentiate into plasma cells after antigen contact, but the 
degenerated plasma cells produce non-functional antibodies and part of antibodies, 
respectively, which are called paraproteins. The multiple myeloma is the most common 
malignant disease of the bone and the bone marrow, respectively. Every year, 4-5 of 100000 
people at an age of 60 to 70 are affected 46. The survival rate was significantly improved by 
introduction of new medicines like Bortezomib, Lenalidomid and Thalidomid within the last 
ten years47-49. However, there is still no treatment available, which can cure the patients 
completely. Moreover, the multiple myeloma influences the bone remodeling compartments 
(BRCs) and corrupts them. In succession, the bone resorption is increased, while the bone 
regeneration is reduced50-51 (see Figure 3.5). This causes osteolytic defects in the bone, 
thereby creating a survival space (“niche”), in which the multiple myeloma cells can 
withdraw during chemotherapy treatment52. 
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Figure 3.5 Osteolytic defects caused by multiple myeloma. a) Osteoblastic bone formation (green) and 
osteoclastic bone resorption (red) are balanced in a normal system. b) By interaction with multiple myeloma 
(brown) cells, the balance is disturbed and the bone resorption is enhanced, while bone formation is decreased. 
Adapted from Seckinger et al.52 
  
Recently, Seckinger et al.53 published the cell death inducing effect of BMP-6 on multiple 
myeloma cells. They showed that BMP-6 reduced the cell viability significantly in 
concentrations higher than 0.160 µg/ml. The highest efficiency could be detected in 
concentration of 4 µg/ml. Furthermore, they could show that BMP-6 could be qualified to 
heal the osteolytic defects due to its high capacity in induction of osteogenic differentiation.  
However, the high amount of BMP-6 which is required to obtain effects in multiple myeloma 
viability makes it unattractive since the systemic treatment in such high concentration would 
likely cause uncontrolled side-reactions in the body. Moreover, the costs for such a therapy 
would be too expensive for patients’ treatment. A delivery system is required, to reduce or 
avoid side-reactions with the locally applied treatment. Additionally, it can help to reduce 
the required amount of BMP-6 in the body. 
 
3.2 Growth factor immobilization  
Growth factors are potent and promising proteins for therapeutically applications in 
regenerative medicine. Especially in replacing or repairing damaged cells, tissues and organs 
transplantations can be avoided or postponed54. To accomplish these aims, different 
approaches to immobilize growth factors had been developed stimulating tissue 
regeneration. Challenges which arise in growth factor immobilization are the requirement to 
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maintain the growth factor’s biological activity and the generation of cell-friendly 
biomaterials.  
 
3.2.1 Immobilization strategies 
There are two main strategies for immobilization: non-covalent and covalent. The non-
covalent method can be further divided into physisorbed or electrostatic interactions, such 
as growth factor’s natural affinity for biomaterial matrices and the affinity for endogenous 
extracellular matrix (ECM). An overview of the different strategies is shown in Figure 3.6. 
 
Non-covalent immobilization by engineered biomatrices 
To face the challenges mentioned above, the focus has been on the use of natural ECM-
derived materials like hyaluronan or chitosan, which offer a physiologically relevant 
environment for cells55 (see Figure 3.6 a). The fibroblast growth factor 2 (FGF-2) and the 
vascular endothelial growth factor A (VEGF-A), for example, bind to fibrin56-57. By using 
fibrin sealants as binding platform, the effect on endothelial cell proliferation and blood 
reperfusion is enhanced58. Another strategy is the direct modification of the biomaterial in 
order to increase the affinity to the growth factors. By tuning gelatin-based hydrogels to be 
more acidic or more basic, the sustained delivery of FGF-2 from negatively charged and of 
BMP-2 from positively charged gels could be shown59-60. Some growth factors bear a 
heparin-binding site, which can be used to immobilize them by using the natural affinity for 
glycosaminoglycans (GAGs) and heparin-like molecules. In this way, strong heparin growth 
factors, such as FGF-2, can be coupled with a heparin-binding domain crosslinked into fibrin 
gels61. Migliorini et al.62 recently published surfaces presenting BMP-2 through heparan 
sulfate (HS), which is a ubiquitous component of the ECM. In this method, the reducing end 
of the HS is used to immobilize BMP-2. Furthermore, the natural arrangement of HS 
proteoglycans in the ECM is mimicked. 
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Figure 3.6 Overview about different strategies for growth factor immobilization. a) By using the natural 
affinity of growth factors to exogenous biomatrices, growth factors can be non-covalently immobilized. b) The 
extracellular matrix can be used as delivery matrix through binding of growth factors via ECM binding 
domains. c) Growth factors can be covalently immobilized to biomatrices by applying chemical or enzymatic 
techniques. Adapted and modified from Mitchell et al.6 
 
Non-covalent immobilization for GF delivery via endogenous ECM components 
ECM proteins and fibers, such as collagen or fibronectin, had become a good and promising 
target for the endogenous binding and presentation of growth factors. By fusion between 
collagen-binding domains (CBD) and growth factors, it could be shown that the delivery of 
a) b)
c)
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the nerve growth factor β (NGFβ) and brain-derived neurotrophic factor (BDNF), 
respectively, by collagen scaffolds improve peripheral nerve and spinal cord regeneration, 
respectively63-64. Similarly, Hauff et al.65 showed the immobilization of biotinylated BMP-2 
to biotinylated cellular fibronectin (cFN) crosslinked by NeutrAvidin. The modification of 
growth factors allows the mimicking of physiological growth factor delivery in order to 
optimize the therapeutic effects on morphogenetic processes. 
 
Covalent immobilization strategies 
Besides the above-mentioned methods, growth factors can be coupled enzymatically to 
biomatrices containing enzymatic sequences. This allows a site-specific control of growth 
factor immobilization, which can reduce the interference with bioactive sites of the growth 
factor to a minimum. Ehrbar et al.66-67 fused a transglutaminase substrate sequence at the 
growth factor terminus to arrange a new connection to fibrin and PEG matrices.  
Due to avoid any uncontrolled diffusion of growth factors, the covalent, chemical 
immobilization onto biomaterials is the method of choice. This method of immobilization 
prevents internalization of the growth factors by cells, which prolongs their lifetime 
compared to the duration of soluble growth factors. These facts might influence the effect of 
the growth factors on cells. In literature, there are many strategies for the covalent 
immobilization of growth factors published68, e.g. using His-Tag coupling. A common 
method is to address primary amines or carboxylate groups of the growth factors as reactive 
moieties by using carbodiimides. Chiu et al.69 crosslinked VEGF-A/angiopoietin-1 to 
collagen scaffolds thus creating a bioactive material, which supports vascularization. 
Another way of covalent immobilization was published by Pohl et al.70-71, who used an 
alkanethiol linker containing an NHS (N-hydroxysuccinimide) ester group to immobilize 
BMP-2 on a homogeneous gold surface by addressing the primary amine groups of the 
protein (see Figure 3.7). To have a better control about the amount of immobilized BMP-2 
on the surface, this method was further developed by Schwab et al.72. Instead of a 
homogeneous gold surface they employed gold nanostructured glass surfaces. To prevent 
unspecific binding of the BMP-2, the space between the gold particles was passivated with 
protein repellent polyethylene glycol (PEG). This approach allowed the determination of the 
amount of the immobilized BMP-2 by knowing the interparticle distance. 
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Figure 3.7 Preparation scheme of immobilized BMP-2 on homogeneous gold surfaces. a) Glass surfaces 
are coated with a gold layer and decorated with a SAM of the MU-NHS linker. Then BMP-2 is covalently 
immobilized with the NHS ester. b) Reaction scheme of the coupling process. Adapted from Pohl et al.70 
 
Since the passivating PEG does not allow cell adhesion on the surfaces, this approach cannot 
be used for studies longer than a few hours. With this approach cells need to be stimulated 
from the top. The space between the surface and the cells harbors only a few µl of culture 
medium. Under these conditions, cells cannot survive for a long time. Therefore, the PEG 
background needs to be modified, which at the same time facilitates cell adhesion. 
 
3.2.2 Adhesive ligands 
Cell migration and adhesion are very essential processes for cells. The heterodimeric 
integrins belong to the most important family of cell adhesion receptors, which serve as 
bidirectional signaling units transducing interaction between the cell and extracellular matrix 
proteins73. These interactions lead to activation of intracellular pathways of integrin 
signaling promoting cell adhesion and migration. Intensive studies since the late 1980s have 
provided structural data revealing ligand recognition sites and biological functions74. At least 
24 subtypes create the integrin family, which can consist of a different assemble of non-
covalent association of 18 α and 8 β subunits75. Integrins control the cell polarity, survival 
and adhesion, in which force transmission from focal adhesions to ECM proteins are 
mediated, known as mechanotransduction76. In 1985, Ruoslahti and co-workers identified 
the integrin dimers αvβ3 and α5β1, which recognize the RGD sequence, a tripeptide 
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consisting of arginine, glycine and aspartic acid77. In 1984, the RGD motif was described as 
the minimal adhesive binding motif78, which means that it is the most simple molecule 
providing cell adhesion. Kessler and co-workers developed cyclic RGD (cRGD) peptides by 
cyclization, introduction of D-amino acids and structural studies in the early 1990s 79-81. This 
peptide can be used to coat surfaces in order to promote cell adhesion. Furthermore, 
Rechenmacher et al.82 described more peptides mentioning integrin αvβ3 and α5β1 selective 
ligands which can be used to generate adhesive layers on surfaces. These ligands specifically 
address β3 and β1 integrin subunits, respectively. They allow the generation of an adhesive 
background in order to promote cell adhesion. Schenk et al.83 described the modification of 
polyethylene glycol containing trimethoxy silane group and alkyne as reactive moieties. By 
applying copper(I)-catalyzed azide alkyne cycloaddition (CuAAC), also known as click 
reaction, ligands such as cRGD and α5β1 selective ligand containing an azide group can be 
coupled to the PEG which are immobilized via the trimethoxy silane to the surfaces (see 
Figure 3.8).  
 
 
Figure 3.8 Schematic illustration of glass surfaces functionalization with PEG containing alkyne. By 
using copper(I)-catalyzed azide alkyne cycloaddition (CuAAC), the PEG layer is functionalized with 
molecules containing azide moieties. Adapted from Schenk et al.83  
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3.2.3 Immobilization of single molecules on gold nanostructured 
surfaces 
Nanotechnology is one of the most promising techniques in the 21st century. It allows for 
usage systems, which are more than three orders of magnitude smaller than the recent 
components of the microelectronics. As mentioned before, the focus of interest has been on 
the immobilization of active proteins like growth factors84, whereas physisorption release 
techniques do not allow to continuously stimulate and control the amount of immobilized 
protein, whereas block copolymer micellar nanolithography (BCMN) enables the control of 
the immobilized protein’s density. The BCMN was established by Prof. Spatz and co-
workers and offers an ideal platform for the investigations of interactions between cells and 
specific ligands or proteins in defined orders and spacings. This technique allows the 
production of nanostructured surfaces in a quasi-hexagonal array. The particle size can be 
varied between 1 - 15 nm and the inter particle spacing adjusted between 30 – 250 nm85-86. 
It is also possible to prepare a gradient spacing. Block copolymers, which consist of a 
hydrophobic polystyrene (PS) and a hydrophobic poly(2-vinylpyridine) (P2VP) unit (see 
Figure 3.9), are used for self-assembling micelles in an apolar solvent. At a concentration 
above the critical micelle concentration (CMC) micelle is reversed formed with the 
hydrophilic P2VP forming the core of the micelle. These micelles are loaded with a metal 
salt such as HAuCl4. 
 
 
 
Figure 3.9 Structure of diblock copolymer. It consists of a non-polar polystyrene block (PS) and a polar 
poly(2-vinyl pyridine) block (P2VP).  
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To coat the micelles on the surfaces, either dip coating or spin coating (see section 5.1.2.3) 
techniques can be applied. Dip coating allows a uniform coverage of various kinds of solid 
substrates over large areas with high accuracy87. Cleaned glass substrates are immersed into 
the micelle solution as described in the scheme (Figure 3.10) and retracted with constant 
velocity. During this step called dip-coating, polymer chains bind to the surface forming a 
micellar monolayer on the surface (see Figure 3.10 a) Another method to form a micellar 
monolayer on the surface is spin-coating. It is described in section 5.1.2.3. Subsequently, the 
substrates are treated with plasma in order to remove all polymers and reduce the gold salt 
to elementary gold forming a quasi-hexagonal array of gold nanoparticle (see Figure 3.10 
b). The resulting nanostructured surfaces can be visualized by using scanning electron 
microscopy (SEM, Figure 3.10 c). 
 
 
 
Figure 3.10 Preparation of nanostructured surfaces by BCMN. a) By immersing glass substrates into 
micellar solution, the block copolymers adsorb on the hydrophilic glass surface. Subsequently, the substrates 
are retracted at constant speed and the solvent evaporates leading to a quasi-hexagonal arrangement of the gold 
nanoparticles on the surface. b) By plasma treatment, the polymer matrix is removed and the gold ions are 
reduced to elementary gold. c) Gold nanostructured surface analyzed by SEM. The average interparticle 
distance is 100 nm (scale bar = 200 nm). Adapted from Baha-Schwab88. 
 
Several parameters influence the spacing of the gold particles. First, the spacing depends on 
the molecular weight of the diblock copolymers corresponding to their length, especially the 
size of the hydrophobic PS unit85, 89-90. Other parameters, which influence the spacing, are 
the concentration of the polymer solution as well as the dipping speed86-87, 91-92. Besides the 
spacing, the size of the gold nanoparticles can be varied from 1 – 15 nm by adjusting the 
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loading of the micellar core with metal salt93. This makes the BCMN favorable to prepare 
precisely tunable gold nanopatterns on surfaces. By controlling the distance between the 
nanoparticles, also the concentration of biomolecules or peptides, which can be immobilized 
using the particles as anchor points, can be varied94-95.  
In this work, BCMN was applied to generate controlled and covalent immobilization of 
growth factors to study their effect on intracellular signal transduction. 80 % of the gold 
nanoparticles carry exactly one protein, while 20 % carry none or two proteins. Based on 
that, the required amount was calculated and reduced to a minimum. Furthermore, it enables 
the long-term investigation of cell stimulation by growth factors. By covalent coating the 
area between the nanoparticles with protein-repellent PEG, unspecific protein adsorption is 
prevented, which facilitates the immobilization of molecules to the gold nanoparticles and 
avoids removing of the nanoparticles. Furthermore, the PEG background can be modified to 
serve as an additional anchor point for other molecules. This enables the co-immobilization 
of cell adhesive ligands between the gold nanoparticles carrying growth factors. This 
approach allows to mimic the natural cell micromillieu under controlled conditions.  
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4 Motivation 
In the last decades, growth factors have been promising candidates for therapeutical 
treatment in regenerative medicine. However, a systemic application is not practicable, since 
uncontrolled diffusion causes a wide range of side-effects. Therefore, the goal of this study 
is to engineer dual functionalized surfaces presenting both, covalently immobilized BMP-6 
and adhesive ligands using thiol-gold interaction and click chemistry for coupling to the 
PEG passivation layer, respectively. This approach was used to investigate the short- and 
long-term effect of the anchored growth factor and the adhesive ligands on C2C12 
differentiation. So far, the chemical covalent immobilization of BMP-6 has not been 
published. However, in line with the approach presented by Pohl et al.70 and Schwab et al.72 
who studied BMP-2 immobilization the amount and the surface density of the immobilized 
protein was controlled. BMP-6 seems to induce bone formation in genetically modified 
MSCs more efficiently than BMP-2. Furthermore, BMP-2 has been shown to cause adverse 
side-effects. This makes BMP-6 to the preferred choice above BMP-2. 
To prove the covalent immobilization of BMP-6, gold surfaces coated with a bifunctional 
thiol-NHS linker and subsequently coupled with BMP-6 by addressing their primary amine 
groups to the surface were used. Block copolymer micellar nanolithography (BCMN) allows 
to fabricate gold nanostructured surfaces hexagonally arranged. These gold particles can be 
utilized to serve as anchor-points for the MU-NHS linker, which allows to determine the 
density and amount of immobilized growth factor by measuring the interparticle distance. 
Furthermore, the passivation of the interparticle space with protein-repellent PEG prevents 
the unspecific binding of BMP-6 to the glass surface. By modification of the PEG layer with 
alkyne moieties, it can be functionalized with cell adhesive ligands bearing an azide group, 
such as RGD and α5β1 integrin selective ligands. This allows the long-term stimulation by 
immobilized BMP-6, since cells are able to adhere to the substrate’s surface. Otherwise cells 
would die. 
In this work, the approach explained above is developed to investigate and characterize the 
ability of immobilized BMP-6 to trigger short-term signaling and to induce osteogenic 
differentiation of C2C12 by long-term stimulation. Moreover, the minimal ligand density of 
iBMP-6 necessary to trigger cell signaling is determined. Finally, the developed set-up shall 
be tested in multiple myeloma cell lines by stimulating with immobilized BMP-6.     
4 Motivation 
22 
 
 
 
 
 
 
 
 
 
 
 5 Material and Methods 
  23 
5 Material and Methods 
5.1 Surface preparation 
5.1.1 Preparation of homogenously coated gold surfaces 
Glass coverslips (H 875 (24 x 24) mm2, H 873 (20 x 20) mm2, Carl Roth & Co GmbH, 
Karlsruhe) were precleaned with precision wipes (Kimberly-Clark Professionals, Koblenz-
Rheinhafen), placed in custom-made Teflon racks and sonicated (Sonorex Super RK 102H, 
BANDELIN electronic GmbH & Co. KG, Berlin) for 15 min in a 1:1 mixture of ethylacetate 
(p.a., Carl Roth) and methanol (p.a. Carl Roth). After rinsing with methanol and drying in a 
nitrogen flow, the clean surfaces were successively coated with a 15 nm chromium layer 
(120 mA, 1.3 x 10-2 mbar, 40 s) and a 50 nm gold layer (60 mA, 5.0 x 10-2 mbar, 60 s) by 
using a MED 020 sputter coating system (BAL-TEC AG, Witten). 
 
5.1.2 Preparation of gold nanostructured surfaces 
5.1.2.1 Activation and cleaning of glass substrates 
Piranha solution, a 3:1 mixture of concentrated sulfuric acid (95 %, Sigma-Aldrich, St. 
Loius, USA) and hydrogen peroxide (30 %, p.a., AppliChem), was used to clean the 
coverslips. The peroxymonosulfuric acid (H2SO5, Caro’s acid) removes organic 
contaminations and activates the glass surface for the passivation with PEG2000 (see section 
5.1.4.2). The substrates were washed with MilliQ water (18.2 MΩ x cm) and dried under 
nitrogen flow. Surfaces were further processed immediately. 
 
5.1.2.2 Preparation of micellar gold solution 
The poly(styrene-b-2-vinylpyridine) diblock copolymer (PS-b-P2VP, Polymer Source Inc., 
Montreal, Canada) (Table 5.1) was dissolved in the appropriate volume of toluene (p.a., 
Merck, Darmstadt) in a glass flask, which was cleaned according to section 5.1.1. The 
solution was stirred at RT for 24 h. Depending on the desired loading rate (L) < 1, which 
describes the molar ratio of P2VP-units and the metal salt HAuCl4, a stoichiometric amount 
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of HAuCl4 trihydrate (Sigma-Aldrich, St. Louis, USA) was added to the prepared solution. 
The amount of HAuCl4 required is calculated by equation 5.1: 
 
𝑚𝑚(𝐻𝐻𝐻𝐻𝐻𝐻𝐶𝐶𝐶𝐶�) =
𝑚𝑚 𝑃𝑃𝑃𝑃𝐶𝐶𝑃𝑃𝑚𝑚𝑃𝑃𝑃𝑃 ∙ 𝑀𝑀 𝐻𝐻𝐻𝐻𝐻𝐻𝐶𝐶𝐶𝐶� 	 ∙ 3	𝐻𝐻�𝑂𝑂 ∙ 𝑃𝑃2𝑉𝑉𝑃𝑃����� 	 ∙ 𝐿𝐿
𝑀𝑀(PS	 + 	P2VP)
 
5.1 
 
Table 5.1 Overview of the characteristics of the polymers used in this work, specified by their chain 
length. PS: polystyrene; P2VP: poly-2-vinylpyridine 
Polymer MPS-block 
[g/mol-1] 
MP2VP-block 
[g/mol] 
PSunits P2VPunits 
PS(30000)-b-P2VP(12500) 30000 12500 288 119 
PS(110000)-b-P2VP(52000) 110000 52000 1056 495 
PS(190000)-b-P2VP(55000) 190000 55000 1824 523 
 
The molecular weight of HAuCl4 depends on the amount of crystal water. In this work 
HAuCl4 trihydrate (M(HAuCl4) = 393.83 g/mol) was utilized. The molecular weight 
M(Polymer) and the amount of P2VPunits of the used polymers are listed in Table 5.1. The 
mixture was stirred for 24 h until all HAuCl4 was dissolved. The micellar solution was 
purified through a polytetrafluoroethylene (PTFE) filter with a pore size of 0.22 µm 
(Millipore, Eschborn) to remove polymer aggregates and undissolved metal salt residues. 
The gold solution was stored under nitrogen atmosphere and light protected. A list of the 
used micellar polymer/gold solution is given in Table 5.2. 
 
Table 5.2 Polymers used for the production of nanopatterns. M: molecular weight of the diblock 
copolymer, c: concentration of the polymer, L: loading or molar ratio between HAuCl4 and PS-b-P2VP 
Polymer M [g/mol] c [mg/l] L 
PS(30000)-b-P2VP(12500) 42500 5 0.5 
PS(110000)-b-P2VP(52000) 162000 5 0.5 
PS(190000)-b-P2VP(55000) 245000 3 0.5 
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5.1.2.3 Spin coating 
The cleaned glass substrates were placed in a ws-650 mz-23 npp spin coater system (Laurell, 
North Wales, USA). Then a specific volume (substrate-size depended: (20 x 20) mm2: 20 µl; 
(24 x 24) mm2: 25 µl) of the gold polymer solution was applied in the center of the spinning 
substrate (9000 rpm). The fluid was spread by the centrifugal force. After evaporation of the 
solvent, substrates were exposed for 45 min to an isotropic microwave-induced hydrogen 
plasma (PVA TePla AG, Wettenberg) to reduce the gold ions to metallic gold and burn off 
the polymer. For this purpose, either a TePla PS 210 (𝑝𝑝𝐻𝐻2 = 0.3 mbar, 600 W) or a TePla100-
E (𝑝𝑝𝐻𝐻2 = 0.4 mbar, 150 W) was used. In the last step, the gold nanoparticle substrates were 
tempered at 300 °C for 72 h by using a drying oven (Binder GmbH, Tuttlingen). Two 
samples of each batch (n = 20) were analyzed by scanning electron microscope (SEM) at 
different positions on the samples. The obtained images were further analyzed by using a 
plug-in for ImageJ (Research Services Branch, Image Analysis Software, NIH, USA) written 
by Dr. Philippe Girard (Institute Jacques Monod, Paris), based on an algorithm developed 
by Kansal et al. In order to ensure a good quality, the order parameter f and the average 
distance between neighboring gold nanoparticles were determined.  
 
5.1.2.4 Dip coating 
Dip coating offers another possibility to decorate glass substrates with a hexagonally ordered 
micellar monolayer. Glass coverslips were retracted from gold polymer solutions (see Table 
5.2) with constant velocity by using a custom-made dip-coating device in order to form a 
micellar monolayer. After evaporation of toluene, substrates were plasma treated as 
described in section 5.1.2.3. Substrates prepared with this method consist of a dipping edge. 
 
5.1.3 Functionalization of homogeneous gold surfaces 
5.1.3.1 Immobilization of heterobifunctional linkers 
In order to immobilize BMP-6 to homogeneous gold surfaces, the heterobifunctional linker 
11-mercaptoundecanoyl-N-hydroxysuccinimide ester (MU-NHS, ProChimia Surfaces, 
Poland) was bound to the gold surface through its thiol group. The MU-NHS was dissolved 
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in DMSO (p.a., Carl Roth) to obtain a final concentration of 1 mM. Substrates with 
homogeneous gold surface were incubated in the solution at RT for 4 h. After removing 
unreacted linker from the surfaces by sonicating in DMSO for 2 min, the substrates were 
rinsed with DMSO and methanol (p.a., Carl Roth) and finally dried in nitrogen stream. 
 
5.1.3.2 Surface immobilization of BMP-6 
The N-hydroxysuccinimide ester group of the linker reacts with free primary amines (Lysine 
residues and N-terminus) of the BMP-6 protein under physiological to slightly alkaline 
conditions (pH 7.5 – 8.5) to obtain a stable amide bond. Lyophilized, glycosylated and 
carrier-free recombinant human BMP-6 expressed in mammalian cells (Genera Research 
d.o.o., Crotia) was dissolved in sterile 4 mM HCl to obtain a stock solution with a 
concentration of 100 µg/ml. Aliquots were stored at -20 °C. The stock solution was diluted 
in PBS (Gibco, Life Technologies GmbH, Darmstadt) containing 1 M NaCl (Sigma-Aldrich, 
St. Lois, USA) in order to obtain a solution with a final concentration of 1 µg/ml (approx. 
33 nM). The BMP-6 solution was adjusted to pH 8.5 immediately prior to use by adjusting 
with 10 mM KOH (Carl Roth).  
 
 
 
Figure 5.1 Immobilization of BMP-6 to homogenous gold surfaces. The heterobifunctional MU-NHS linker 
binds through its thiol group to gold surfaces. Afterwards BMP-6 is covalently coupled to the NHS ester by 
free primary amines.  
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In custom-made poly(dimethyl siloxane) (PDMS, Sylgard 184, silicone elastomer kit, Dow 
Corning, Midland, USA) chambers MU-NHS-functionalized surfaces were incubated with 
the BMP-6 working solution overnight at 4°C. After sonication in PBS containing 1 M NaCl 
for 1 min, the substrates were washed three times in PBS / 1 M NaCl to remove unbound 
protein. 
The surface concentration of the immobilized BMP-6 (Γ= amount of BMP-6 on the surface 
/ surface area) was calculated by the equation 5.2: 
 
𝛤𝛤(𝐵𝐵𝑀𝑀𝑃𝑃 − 6) = 	
𝑀𝑀	 𝐵𝐵𝑀𝑀𝑃𝑃6
𝑎𝑎𝑃𝑃𝑃𝑃𝑎𝑎	 𝐵𝐵𝑀𝑀𝑃𝑃6 	×	𝑁𝑁�
= 	
30000
𝑔𝑔
𝑚𝑚𝑃𝑃𝐶𝐶
(8	𝑛𝑛𝑚𝑚)�	×	
3
4 	×	6.022	×	10
��	𝑚𝑚𝑃𝑃𝐶𝐶��
	≈ 80	𝑛𝑛𝑔𝑔/𝑐𝑐𝑚𝑚  
5.2 
 
The following parameters were assumed: 
I) The diameter of a BMP-6 dimer is approximately 8 nm.  
II) The molecular weight of a dimer is 30000 g/mol.  
III) The binding of BMP-6 by the MU-NHS linker to the surface follows a hexagonal 
distribution70. 
 
5.1.4 Functionalization of gold nanostructured glass surfaces 
5.1.4.1 Synthesis of PEG2000 and PEG3000-alkyne 
α-Methoxy-ω-amino poly(ethylene glycol) (Iris Biotech GmbH, Germany) (1 g, 0.5 mmol, 
MW 2160 g/mol) and α-amino-ω-propargylacetamido poly(ethylene glycol) (1.66 g, 
0.5 mmol, MW 3317 g/mol), respectively, were dissolved in dry DMF (4 ml, p. a., Carl 
Roth) under argon atmosphere and stirred for 10 min. 1.1 equivalents of 3-(triethoxysilyl) 
propylisocyanate (95 %, Sigma Aldrich) were added and the mixture was stirred at RT for 
16 h. The reaction was cooled down to 0 °C for 10 min and a 10-fold excess of ice-cold 
diethyl ether (Sigma-Aldrich) was added. After 1 h the suspension was filtrated and the 
precipitate was washed with cold ether. The purified product was dried under reduced 
pressure for 24 h to yield a white powder. Synthesis was performed in cooperation with F. 
Schenk (Physical Chemical Institute, Heidelberg University) and the characterization of the 
product is described in Schenk et al.83 in detail (Figure 5.2). 
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Figure 5.2 Synthesis of PEG2000 (A) and PEG3000-alkyne (B). Condensation of α-methoxy-ω-amino 
poly(ethylene glycol) (m = 47) and 3-(triethoxysilyl) propylisocyanate (A). Condensation of α-amino-ω-
propargylacetamido poly(ethylene glycol) (n = 72) and 3-(triethoxysilyl) propylisocyanate (B). 
 
5.1.4.2 Covalent immobilization of PEG2000 
The space between gold nanoparticles was passivated with a protein repellent PEG2000 
monolayer in order to avoid non-specific protein and cell interactions with glass. The 
triethoxysilane groups of PEG2000 react with the silicon dioxide covalently coupled to the 
surface (Figure 5.3).  
Nanopatterned substrates were activated in reactive oxyden plasma (𝑝𝑝𝑂𝑂2 = 0.4 mbar, 150 W) 
for 10 min. Afterwards the surfaces were immersed in a solution of 250 µM PEG2000 in dry 
toluene (p.a., Merck) and 0.01 equivalents of triethylamine (≥99.5 %, Sigma Aldrich) at 
80 °C for 14 h under argon atmosphere. The samples were sonicated in ethylacetate (p. a.) 
and methanol (p. a.) for 5 min each. The substrates were rinsed with methanol and dried in 
A 
B 
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a stream of nitrogen to be immediately processed. The covalent coupling of BMP-6 was 
performed as described in section 5.1.3. 
 
 
 
Figure 5.3 Passivation of gold nanostructered glass substrates. After activation of glass surfaces in 
hydrogen plasma, PEG2000 was covalently coupled to the substrate. 
 
Table 5.3 Surface density of immobilized BMP-6. Gold NP = gold nanoparticle 
Inter particle 
distance 
d [nm] 
No. of gold 
NP per µm2 
 
No. of gold NP 
with iBMP-6 per 
µm2 
Density of 
BMP-6 on the 
surface [ng/cm2] 
Amount of 
BMP-6 per 
sample [ng] 
32 ± 8 803 ± 54 723 3.3 19 
63 ± 11 281 ± 17 253 1.1 6 
107 ± 21 51 ± 12 46 0.2 1 
 
The inter particle distance between the Au nanoparticles was used to determine the average 
number of gold nanoparticles per µm2 to calculate the amount of immobilized BMP-6 (Table 
5.3). The analysis of the SEM images served as the basis of the calculation (see 
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section 6.2.2.1). These took into account the order parameter and not the theoretical values, 
because this would assume a perfectly hexagonal order, what is impossible. Assuming a 
coverage of 90 % of the gold nanoparticles harbor at least one BMP-6 dimer, it was 
determined that the number of gold nanoparticles per µm2 is equal to the number of iBMP-
6.  
These assumptions based on AFM measurements on passivated gold nanostructured 
substrates with covalently immobilized BMP-2 on the nanoparticles. Measurements and 
determination of the nanoparticle-BMP-2 binding ratio were performed by Dr. Theresa 
Pohl96. 
 
5.1.5 Dual functionalization of gold nanopatterned glass surfaces 
The dual functionalization is an improved development of the gold nanostructured 
surfaces83. This allows the independent immobilization of a second single molecule on the 
surface. The space between the gold nanoparticles was coated with a PEG2000 and 
PEG3000-alkyne mixture. This enables to immobilize the second molecule through the 
copper(I)-actalyzed azide alkyne cycloaddtion (CuAAC), also known as the click reaction. 
K. Barry Sharpless introduced this term in 200197, naming a decisive development of a set 
of highly reliable and selective reactions, which allow for the covalent bonds between 
molecules having different functional groups. 
 
5.1.5.1 Passivation with PEG2000 and PEG3000-alkyne 
Nanopatterned substrates were activated in reactive oxygen plasma (𝑝𝑝𝑂𝑂2 = 0.4 mbar, 150 W) 
for 10 min. Afterwards the surfaces were immersed in a mixture of 250 µM PEG2000 and 
2.50 µM PEG3000-alkyne in dry toluene (p.a., Merck) and 0.01 equivalents of triethylamine 
(≥99.5 %, Sigma Aldrich) at 80 °C for 14 h under argon atmosphere (Figure 5.4). The 
samples were sonicated in ethylacetate (p. a., Merck) and methanol (p. a., Sigma Aldrich) 
for 5 min each. The substrates were rinsed with methanol and dried in a stream of nitrogen 
to be processed immediately. 
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Figure 5.4 Passivation and functionalization of gold nanostructured glass substrates. After activation of 
glass surfaces in oxygen plasma, PEG2000 and PEG3000-alkyne were covalently bound to the substrate 
surface. Adapted and modified from Martin et al.98 
 
5.1.5.2 Coupling of peptides by CuAAC 
The copper(I)-catalyzed azide-alkyne cycloaddition can be performed at RT and in aqueous 
solvents. Furthermore, the wide pH range from 4 – 12, the enormous turnover rate (107 – 108) 
compared to the non-catalyzed click reaction and the tolerance of a wide spectra of 
functional groups make the CuAAc to one of the most favorable reactions. Sodium ascorbate 
reduces the Cu(II) species to the active Cu(I) catalyst. 
Click reaction was performed according to Schenk et al.83. Glass substrates passivated with 
PEG3000-alkyne (section 5.1.5.1) were incubated with 50 µl of a freshly prepared reaction 
solution containing 100 mM L-ascorbic acid, 100 mM Tris HCl (pH 8.5), 0.15 mM azide-
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containing molecule and 1 mM CuSO4 in a humidity chamber at RT for 2 h. Samples were 
washed three times with MilliQ water, dried in a stream of nitrogen and immediately 
processed (Figure 5.5).  
 
 
 
Figure 5.5 Functionalization of PEG passivated background by introduction of azide-containing 
peptides through azide-alkyne cycloaddition reaction. 
 
In this work, two different adhesion molecules were coupled to the PEG3000-alkynethe by 
their azide moieties. The α5β1-integrin-selective peptidomemetic (Figure 5.6 A) is an 
artificial ligand, which binds strongly to integrin α5β1 resulting in cell adhesion, that is 
selectively mediated by this specific integrin heterodimer82. The molecule was kindly 
provided by Prof. Dr. Horst Kessler (TU Munich). The tripeptide motif RGD, which is 
present in many ECM proteins, is known to induce cell adhesion99-102. The cyclic peptide 
c(RGDfE)K(N3) (cRGD-azide) (PSL Peptide Specialty Laboratories GmbH, Heidelberg) 
contains this motif and serves as a ligand for several integrins (Figure 5.6 B). 
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A           B 
    
 
Figure 5.6 Chemical structure of α5β1-integrin-selective peptidomimetic (A) and cyclic RGD (B). 
Functionalization of surfaces with the peptidomimetic (A) and cyclic RGD (B) results in cell adhesion, 
whereby cell adhesion, induced by A, is selectively mediated by integrin α5β1.  
 
5.1.6 Preparation and functionalization of gold nanostructured 
PEG-DA hydrogels 
5.1.6.1  Synthesis of polyethylene glycol diacrylate (PEG10000-DA) 
In this work polyethylene glycol-diacrylate with a molecular weight of 10000 g/mol was 
used and synthesized according to Elbert et al.103 with the technical support of Radka Koelz 
(Max-Planck Institute for Intelligent Systems, Stuttgart) (Figure 5.7). PEG10000 (50 g, 
5 mmol; Iris Biotech GmbH, Germany) was dissolved in dichloromethane (125 ml, Sigma 
Aldrich) and toluene (75 ml, Merck) under nitrogen atmosphere. Triethylamine (1.4 ml, 
10 mmol, Sigma Aldrich) and acryloyl chloride (1.25 ml, 15 mmol, Sigma Aldrich) were 
added and the reaction mixture was stirred at RT for 16 h. The raw product was filtered 
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through Al2O3 (Roth). K2CO3 (12.5 g, 90.5 mmol, Roth) was added and the solution was 
stirred at RT for 1.5 h. The mixture was filtered again through Al2O3 and the solvent was 
removed under reduced pressure. The residue was dissolved in diethyl ether (400 ml, Roth) 
while stirring. The suspension was filtered and washed with diethyl ether. The PEG10000-
DA was dried under vacuum. 
 
 
 
Figure 5.7 PEG-DA synthesis. Condensation of PEG10000 and acryloyl chlorid.  
 
5.1.6.2 Preparation of gold nanostructured PEG-DA hydrogels 
To optimize the handling during the experiments, the gold nanostructured hydrogels were 
prepared as glass-supported gels. For this, glass substrates were cleaned as described in 
section 5.1.2.1 and activated in reactive oxygen plasma (𝑝𝑝𝑂𝑂2 = 0.4 mbar, 150 W) for 10 min. 
Followings, the substrates were placed in a desiccator together with 1 ml (3-
aminopropyl)triethoxysilane (APTES, Alfa Aesar) under vacuum. At the following day, the 
functionalized surfaces were removed from of the silane atmosphere. After the unbound 
APTES volatilized the substrates were used for the copolymerization to bind the hydrogels. 
The gold nanostructured glass substrates (section 5.1.2) were incubated in 2 mM solution of 
N,N-bis(acryloyl)-cystamine (Alfa Aesar, Karlsruhe) in pure ethanol at RT for 1 h. 
Afterwards unbound linker was removed by washing with pure methanol and substrates were 
dried under nitrogen stream. Figure 5.8 shows the procedure of the hydrogel synthesis. 
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Figure 5.8 Preparation of gold nanostructured hydrogels bound to a glass surface. (A) The gold 
nanoparticles, which orientated in a quasi-hexagonal structure on the glass surface, were transferred to the 
hydrogel during the polymerization process by using (N,N-bis(acryloyl)cystamine) as crosslinker. (B) The 
glass substrate was functionalized with (3-aminopropyl)triethoxysilane after cleaning and activating. (C) The 
PEG-DA-solution, containing APS and TEMED, was pipetted onto the APTES functionalized glass substrate 
and covered by in (A) prepared surfaces. Since the polymerization started immediately after addition of APS 
and TEMED, the embedding needed to be done quickly. After 30 min in darkness, the substrate was placed in 
pure water. Here, the glass coverslip on top started detaching, induced by the swelling process of the hydrogel, 
while the gold nanoparticles remained attached to the hydrogel. Thus, the gold structure was transferred to the 
hydrogel surface, which was bound to the lower coverslip. 
 
The PEG-DA (MW : 10000 g/mol) was dissolved in degassed water to obtain a final 
concentration of 150 mg/ml and stirred at RT for 30 min. Afterwards, a 10 % (w/v) solution 
of the polymerization initiator ammonium persulfate (APS) in degassed water and the 
polymerization catalyst tetramethylethylenediamine (TEMED) were added to the PEG 
mixture. APS was used in a concentration of 0.35 µl/mg PEG-DA and TEMED was used in 
a concentration of 0.05 µl/mg PEG-DA. This PEG-initiator solution was embedded between 
the gold nanostructured surface, functionalized with N,N-bis(acryloyl)cystamine linker, and 
the activated glass substrates containing APTES. By adding APS and TEMED the cross-
polymerization between the unsaturated acrylate groups of each linker and the PEG solution 
was initiated. This results in chemical bonding of the hydrogel to the glass substrate and the 
transfer of the gold nanoparticle. The samples were covered with aluminum foil at RT for 
30 min. The preparation was done in a custom-made Teflon™ form of 25 mm x 25 mm. The 
size of the synthesized hydrogels is determined by the used coverslips (24 mm x 24 mm). 
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The substrates were placed in either pure water or sterile PBS for 48 h in order to allows 
swelling to equilibrium. They were stored in the dark at 4 °C. In Figure 5.9, the mechanism 
of chain propagation during the cross-polymerization is shown. In this way, the gold 
nanoparticles are coupled covalently to the hydrogel surface and the hydrogel is tethered on 
the glass coverslip.  
 
A             B 
 
 
Figure 5.9 Mechanism of the cross polymerization. (A) Transfer of the gold nanoparticles by crosslinking 
of PEG-DA and the N,N-bis(acryloyl)cystamine linker. (B) Binding of the hydrogels to the glass substrates. 
The (3-aminopropyl)triethoxysilane, bound to the glass surface, reacts in a radical reaction with the 
polymerized PEG-DA. 
 
The MU-NHS was dissolved in DMSO to obtain a final concentration of 100 mM. Then, 
this solution was diluted with water to a final concentration of 1 mM. The hydrogels with 
gold nanostructured surface were incubated in the diluted solution at RT for 4 h. After 
removing unreacted linker from the surfaces by sonicating in water for 2 min, the substrates 
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were rinsed with PBS. The covalent immobilization of BMP-6 was performed as described 
in section 5.1.3.2. 
 
5.1.6.3 Generating an adhesive background on PEG-DA hydrogels 
In order to induce cell adherence to hydrogels, different methods were used to generate an 
adhesive background on gold nanostructured PEG-DA hydrogels. 
 
5.1.6.3.1 PLL coating 
After BMP-6 immobilization, gels were incubated with a 0.1 mg/ml solution of Poly-L-
lysine–FITC labeled (MW ~ 15000 – 30000, Sigma Aldrich) in MilliQ water at RT for 1 h. 
Before usage, the substrates were washed with MilliQ water three times on a shaker for 
10 min. 
 
5.1.6.3.2 Incorporation of cyclic peptide c(RGDfE)K(N3) into hydrogels 
To incorporate cRGD-azide into the hydrogel, cRGD was added to the PEG-DA polymer 
solution (section 5.1.6.2) in three different concentrations (1.5 mM, 0.15 mM and 
0.015 mM). PEG-DA and cRGD were mixed before adding APS and TEMED. The 
polymerization was performed according to section 5.1.6.2. 
  
5.2 Surface characterization 
5.2.1 Characterization of functionalized substrates 
5.2.1.1 Quartz crystal microbalance with dissipation (QCM-D) 
Fundamentals: 
The principles of a QCM-D are based on the inverse piezoelectric effect. An electric 
potential is generated in dielectric crystals with permanent dipoles and symmetric 
distribution of charges, if the charges are moved by mechanical stress. This effect can be 
observed in the opposite direction as well. By applying an external voltage, a deformation 
of the crystal structure is induced. By using alternating current voltage, the crystal starts 
oscillating. If the excitation frequency matches with the resonance frequency f0, it results in 
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resonance. After turning off the alternating current voltage, the crystal continues to vibrate 
mechanically. This oscillation can be quantified by measuring the reducing electrical field. 
The decrease of the damped oscillation’s energy compared to the total energy is called 
dissipation (D). In equation 5.3, the resulting oscillation is described.  
 
𝐻𝐻 𝑡𝑡 = 	𝐻𝐻� exp −𝜋𝜋𝜋𝜋𝜋𝜋𝑡𝑡 sin	(2𝜋𝜋𝜋𝜋𝑡𝑡 + 𝜃𝜃) 
5.3 
Here, A0 is the start amplitude of vibration, f is the frequency and θ is the phase angle of f. 
Considering the dissipation conclusion about the properties of the adsorbed masses can be 
made. Soft and inert masses cause higher dissipation than rigid masses. In case of an elastic 
and soft adsorbate, the crystal slows down faster.  
 
A quartz crystal can be used as mass sensor, since the oscillation frequency is decreased by 
coating with either a rigid or a soft and elastic mass. Besides the basic oscillation, the odd 
overtones (n=1, 3, 5,…13) are able to induce resonance vibration. The relation between the 
frequency modulation and the adsorbed mass is given by the Sauerbrey equation 5.4104. 
 
                                                                ∆𝑚𝑚 = 	− ��	��
���
� ×	
∆�
�
= 	−𝐶𝐶	
∆�
�
 
5.4 
 
The mass sensitivity constant C summarizes ∆m = mass difference, ∆fn = frequency 
difference and the specific variables of the quartz, ∆	𝜌𝜌 = quartz density (2.65 ng × cm-2), υq = 
sound velocity in the crystal (3340 m × s-1). The sensor of the E4 sensor system has a value 
of 17.7 ng × cm-2Hz for the mass sensitivity constant C in liquid. To apply the Sauerbrey 
equation, the following conditions for the adsorbed masses need to be fulfilled: a) the mass 
must be rigid, b) the mass must not shift, c) the mass must be homogeneously distributed on 
the crystal and d) the mass must be small compared to the mass of the crystal. Therefore, 
deviations will appear in measurements of soft masses. To avoid these variations, there are 
different measuring methods like surface plasmon resonance (SPR)105, reflectometry106 and 
ellipsometry107. These methods can only be used for the analysis of dry masses, whereas in 
QCM-D measurements, only hydrated masses are measured. Since the experiments in this 
work were performed in liquid, the QCM-D was the method of choice. 
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The formation of a self-assembled monolayer (SAM) of MU-NHS linker on an Au surface 
and the subsequent immobilization of BMP-6 were observed by using a quartz crystal 
microbalance. The measurements were performed with the E4 sensor system from Q-Sense 
(Västra Frölunda, Sweden) in an open module at RT and the software QSoft401 (version 
1.4.2). The analysis was done with QTools (version 2) 
 
5.2.1.2 X-ray photoelectron spectroscopy (XPS) 
X-ray photoelectron spectroscopy is a surface-sensitive, established method to analyze the 
chemical composition of solid substances and determine nondestructively their surfaces, 
respectively. Furthermore, it allows identification and quantification of chemical elements 
and their chemical environment (oxidation state) with a depth of max. 10 nm as well as 
information about the oxidation levels and binding states can be obtained. XPS belongs to 
the group of photoemission spectroscopy (PES) methods. PES in general and XPS in 
particular are based on the physical principle of Einstein’s photoelectric effect. By 
irradiation of a surface with electromagnetic radiation, which has an energy h𝜈𝜈 higher than 
the work of emission Φ of the sample, the difference between the vacuum energy Evac and 
the Fermi energy EF, electrons are excited from occupied ground states to unoccupied, 
unbound end states of the sample (Figure 5.10)108. This means, that electrons are released 
from the sample, where their speed can be measured. The kinetic energy Ekin of an irradiated 
electron can be described by equation 5.5: 
 
                                                                        𝐸𝐸𝑘𝑘𝑘𝑘𝑛𝑛 = ℎ𝜐𝜐 − 	𝐸𝐸𝐹𝐹 − 	Φ  
5.5 
 
XPS examines emissions of low-energy electrons in the range of 20 – 2000 eV. Aluminum 
(1486.7 eV) and magnesium (1253.6 eV) are typical X-ray sources. The binding energy EB 
of a core electron in a solid refers to the Fermi energy EF. Therefore, EB can be determined 
by measuring Ekin and using equation 5.5. This leads to peak position of the referring 
chemical element109. The peak position can be shifted up to 10 eV caused by the chemical 
environment and the oxidation state, respectively. Core electrons don’t have high possibility 
to scatter inelastically. For this reason, the kinetic energy of electrons, which scatter 
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inelastically, cannot be used for determination of binding energy and appear only in the 
background of the spectra108, 110. 
To determine the time, in which the NHS ester is stable in aqueous solvent, three conditions 
were chosen: 1st surfaces coated with homogenous gold were decorated with MU-NHS linker 
as described in section 5.1.3.1. 2nd Surfaces were incubated in PBS for 20 min at RT after 
decoration with MU-NHS. 3rd Surfaces were incubated with MU-NHS linker in DMF for 
only 20 min at RT. Substrates were shortly rinsed with MilliQ water, dried in nitrogen flow 
and analyzed by XPS MAX 200 photoelectron spectrometer (Leybold-Heraeus, Cologne) 
with Mg Kα radiation source (1253.6 eV) operated at 220 W and in ultra-high vacuum below 
10-8 mbar. For the acquisition of the spectra emitted electrons were collected perpendicularly 
to the sample surface with a hemispherical electron energy analyzer at constant pass energy 
of 96 eV and 48 eV for overview spectra and detailed spectra, respectively. 
 
 
Figure 5.10 Scheme of the XPS functioning process. An atom emits an electron from the 1s energy level 
after photoionization by X-ray irradiation108, 110. 
 
The recorded spectra were normalized by the spectrometer specific transmission function, 
which is specific for the spectrometer. The binding energy was calibrated to 84.0 eV for 
elemental gold in order to compensate electrostatically charging of the samples111. The 
spectra were analyzed with the software XPS Peak 4.1112. Spectra were background corrected 
for signal quantification by subtracting the background according to Shirley and fitted by a 
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symmetric Voigt function with a variable Gauß-Lorentz product function. The spectra were 
plotted in Origin 8.5.  
 
5.2.1.3 Infrared reflection absorption spectroscopy (IRRAS) 
The IR spectroscopy is a qualitative spectroscopy method and based on the stimulation of 
vibrational energy states in molecules. In this method, the substrate is irradiated by mid 
infrared radiation (100 to a few 1000 cm-1). Specific wavelengths are absorbed by the 
substance, because their energies stimulate the vibration of molecule groups. This results in 
absorption bands at the related wave numbers in the spectrum. The infrared spectrum is 
characteristic for every molecule and can be used to identify substrates. 
 
In this work, surfaces coated with a homogeneous gold layer (section 5.1.1) and decorated 
with self-assembled monolayer (SAM) of MU-NHS linker (section 5.1.3.1) were analyzed 
by using a IFS 66v/S Vacuum FT-IR system (Bruker Optics, Billerica, USA). The substrates 
were rinsed with MeOH and dried in nitrogen flow before placing in the analytical chamber. 
The measuring time for both the sample and the background was 180 s each (200 scans). 
The scans were performed in reflection mode in vacuum (10-3 mbar) with a resolution of 
4 cm-1. The detector was a DTGS and the thermal light source was globar. The spectra were 
recorded in a range from 400 – 4000 cm-1. The effective analyzed range was from 
1000 – 3000 cm-1.  
 
5.2.1.4 Scanning electron microscope (SEM) 
The scanning electron microscopy is a surface-sensitive, penetration depth imaging method, 
which uses electrons to analyze samples. During the process the sample is scanned line wise 
by a highly-focused electron beam and the intensity of the emitted secondary electrons is 
determined by a detector (Figure 5.11). For this reason, the SEM is also called secondary 
electron microscope.  
 
5 Material and Methods 
42 
 
 
Figure 5.11 Mechanism of emission of a secondary electron. By interaction with the primary electron (PE), 
a valence electron is knocked out of orbital and detected as a secondary electron (SE)113. 
 
Since a primary electron is able to generate several secondary electrons by interaction with 
the sample, the sample needs to be conductive. Non-conductive samples can be sputtered 
with gold or graphite in order to analyze them by SEM. The working electron energy of a 
SEM is about 20 keV. Normally, a few keV are used to limit the maximum depth of SE to 
10 µm. By using a primary energy < 1 keV, the maximum depth can be reduced to a few 
nanometers. Therefore, with SEM primarily the sample surface is visualized. Several 
detectors can be used during the scanning process.  
 
 
 
Figure 5.12 Scheme of a scanning electron microscope. The positions of the different detectors (SE1 and 
SE2 types) and the origin of the secondary electrons are shown. Modified and adapted from Kuo et al.114 
 
 5 Material and Methods 
  43 
Depending on the position of the detector, the images of the same sample can be visualized 
completely different, because the information is collected from different depths and angles 
of sample. The In-Lens-detector is perpendicular to the sample and it detects mainly 
electrons, which are refracted and reflected by elastic scattering with the atoms. Therefore, 
they are called backscattered electrons (BSE, type SE1) and origin from the upper layer of 
the sample. The SE2 detector is fixed in a 45 ° angle to the sample. The SE2 electrons are 
derived from deeper layers of the sample113. A scheme of an SEM is shown in Figure 5.12. 
 
In this work, the gold nanopatterned surfaces were analyzed by SEM after plasma treatment 
and tempering. Since the surfaces are not sufficiently conductive, they were coated with a 
thin conductive layer of graphite (~ 5 nm) by using EM ACE200 sputter coating system 
(Leica, Wetzlar). Imaging was performed using a LEO 1530 (Carl Zeiss, Jena). The spacing 
and the order of the gold nanoparticles were measured by using amagbificatio of 50000x and 
100000x and analyzed using the dot analyzer plug-in created by Dr. Phillipe Girard for 
ImageJ (Research Services Branch, Image Analysis Software Version 1.51h, NIH, USA). 
The average distance between neighboring gold nanoparticles was determined and averaged 
over N particles with this plug-in. The order parameter Φ ranges from 0 to 1, with 1 being a 
perfect hexagonal order. Only samples with an order parameter > 0.5, were used for 
experiments. 
 
5.2.1.5 Atomic force microscopy (AFM) 
To determine the elasticity of the hydrogels an atomic force microscope Nano Wizard I was 
used (JPK Instruments AG, Berlin). The device was installed on an inverted microscope 
(Axiovert 200, Carl Zeiss, Jena). The measurement of the hydrogels was performed by 
indentation of a CONT-Silicon-SPM-Sensor cantilever with colloidal particle (CP-CONT-
BSG-A, sQUBE, Bickenbach, Germany). The cantilever had a thickness of 2.0 ± 1 µm, a 
length of 450 ± 10 µm and a width of 50 ± 7.5 µm. The force constant was determined by 
calibration with the thermal noise and was in the range of 0.02 – 0.77 N/m. The colloid 
particle consisted of borosilicate glass and had a diameter of 5 µm. The obtained data were 
analyzed with AtomicJ (Version 1.7.2_OS Independent)115 and further edited with Microsoft 
Excel for Mac 2016. The AFM measurements of the PEG-DA hydrogels and the analysis 
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were done in cooperation with Dr. Carolina Diaz (Physical Chemical Institute, Heidelberg 
University). 
 
5.2.2 Detection of iBMP-6  
5.2.2.1 Chemiluminescence detection 
Surfaces, either homogeneous gold coated or gold nanostructured, functionalized with 
iBMP-6 were prepared as described above (section 5.1.3.2). Samples were blocked in a 
solution of 3 % (w/v) BSA (Carl Roth) in PBS at RT for 1 h followed by incubation with 
5 µg/ml anti rhBMP-6 mouse IgG (R&D Systems, Wiesbaden) in a solution of 1 % (w/v) 
BSA in PBS at RT for 1 h. After washing with PBS three times at RT for 10 min, the samples 
were incubated with 0.1 µg/ml secondary anti-mouse IgG conjugated with horseradish 
peroxidase (HRP) enzyme (Santa Cruz, Heidelberg) in a solution of 1 % (w/v) BSA in PBS 
at RT for 1 h. Finally, surfaces were washed with PBS three times at RT for 10 min. In order 
to reveal the specific signal, samples were incubated with ECL Plus Western Blotting 
Detection Kit (GE Healthcare, Little Chalfont, Great Britain) and imaged by using a 
luminescent imaging analyzer Amersham Imager 600 (GE Healthcare, Little Chalfont, Great 
Britain). 
 
5.2.2.2 Indirect immunofluorescence 
The preparation of the different surfaces was performed as described in section 5.2.2.1 until 
primary antibody incubation. After washing with PBS three times at RT for 10 min, the 
samples were incubated with secondary antibody Alexa Fluor 488 goat anti-mouse IgG 
(Invitrogen, Carlsbad, USA) in a final concentration of 1 µg/ml in a solution of 1 % (w/v) 
BSA in PBS at RT for 1 h. Then, samples were washed again three times in PBS at RT for 
10 min followed by immunofluorescence microscopy with an upright wide field microscope 
Leica DM 6000B (Leica Microsystems, Wetzlar). Cells were examined with a 10x air 
objective lens (Leica). The images were adjusted in brightness and color with ImageJ 
software (Research Services Branch, Image Analysis Software, NIH, USA).  
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5.3 Cell culture 
5.3.1 Cell lines and culture conditions 
Mouse C2C12 myoblasts (CRL-1772, ATCC, Wesel, Germany) are a standard model system 
employed for the investigation of bone morphogenetic proteins and known to respond to 
BMP-632. Cells were cultured as sub-confluent monolayers (~80 %) in growth medium 
(DMEM containing 4.5 g/l D-glucose, L-glutamine, pyruvate, phenol red; Thermo Fisher, 
Darmstadt) supplemented with 10 % (v/v) fetal bovine serum (FBS, Biochrom, Berlin) and 
1 % (v/v) penicillin/streptomycin (Gibco, Life Technologies) at 37 °C and 5 % CO2 in a 
water saturated atmosphere and the medium was renewed every 2 - 3 days. Upon reaching 
70 – 80 % confluence, cells were detached by accutase treatment (Life Technologies) and 
subcultured at a dilution of 1:10. To exclude false positive results induced by possible traces 
of BMP in the FBS, cells were incubated 6 days in the presence of FBS to observe myotube 
formation by phase contrast microscopy.  
The multiple myeloma cell line OPM-2, established from the peripheral blood of a woman 
aged 56 yearswith multiple myeloma (IgG lambda) in leukemic phase, are suspension cells 
and were purchased from DSMZ (German Collection of Microorganisms and Cell Cultures, 
Braunschweig). Cells were cultured in growth medium (RPMI 1640 containing 4.5 g/l D-
glucose, L-glutamine, pyruvate, 2 g/l NaHCO3; Biochrom, Berlin) supplemented with 10 % 
(v/v) FBS and 1 % (v/v) penicillin/streptomycin, 5 % CO2-atmosphere at 37 °C in a water 
saturated atmosphere and the medium was renewed every 2 - 3 days. 
 
5.3.2 Mycoplasma test 
To detect contamination of mycoplasma, cells were tested after thawing. 5 x 104 cells were 
incubated in DMEM containing 10 % (v/v) FBS in cell culture flask for 24 h. Then, 2 ml of 
culture supernatant was collected and tested by using the MycoAlert Mycoplasma Detection 
Kit (Lonza, Basel, Switzerland). The samples were prepared according to the manufacturer’s 
protocol and analyzed by a luminometer Infinite M200 (Tecan, Männedorf, Switzerland). 
Only cells which did not have any mycoplasma contamination were used in this study. 
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5.3.3 Cell experiments  
For experiments with substrates coated with homogeneous gold (section 5.1.3) and gold 
nanostructured surfaces (section 5.1.4), cells were seeded in custom-made poly(dimethyl 
siloxane) (PDMS) chambers (Sylgard 184, silicone elastomer kit, Dow corning) with  a 
density of 1x105 cells/chamber under standard culture conditions. After 24 h cells were 
starved in serum-free DMEM for 5 h. Then, the medium was replaced by 50 µl of serum-
free medium per chamber. Cells were stimulated either with substrates containing BMP-6 
(iBMP-6, section 5.1.3.2), with soluble BMP-6 in DMEM, whereby the concentration is 
related to the amount of iBMP-6, (sBMP-6, as positive control) or with only a substrate 
without iBMP-6 (Ctrl, as negative control) (Figure 5.13). Cells were covered with the 
different substrates from top. After gently removing the substrates, cells were checked for 
integrity by using phase contrast microscopy (Axiovert 40C, Carl Zeiss). 
 
 
 
Figure 5.13 Scheme of cell stimulation from top by iBMP-6 substrates. Adherent cells were short-term 
stimulated from top either by surfaces coated with homogeneous gold (left) or by gold nanostructured surfaces 
(right); with soluble BMP-6 in culture medium (sBMP-6) or with immobilized BMP-6 (iBMP-6). 
 
For experiments with dual functionalized substrates (section 5.1.5) and gold nanostructured 
PEG-DA hydrogel substrates (section 5.1.6), cells were starved in serum-free DMEM for 
5 h. Substrates were placed in custom-made poly(dimethyl siloxane) (PDMS) chambers. 
Cells were washed with PBS, detached by using accutase (Life Technologies) and seeded 
on the substrates in a density of 1 x 105 cells/substrates (24 x 24 mm2) in 2 ml of cell culture 
medium. As positive control, sBMP-6 was added in culture media right before seeding cells 
on substrates (Figure 5.14). Before lysing, cells were checked for integrity by using phase 
contrast microscope. 
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Figure 5.14 Scheme of cell stimulation from bottom by iBMP-6 substrates. Cells were seeded onto the 
substrates for long-term responses e.g. inhibition of myotube formation or alkaline phosphatase assay. 
 
5.4 Molecular biological methods 
5.4.1 Preparation of cell lysates 
After removal of culture medium, cells were washed three times with cold PBS. Then, 50 µl 
of RIPA lysis buffer (Sigma Aldrich) complemented with Halt Protease Inhibitor Single-
Use Cocktail (Thermo Fisher, Waltham, USA) and 5 mM EDTA (Thermo Fisher) was added 
per well. After incubation at 4 °C for 30 min, cells were detached from the culture well by 
using a cell scraper. Samples lysates were separated from cell debris by centrifugation in a 
precooled centrifuge at 14000 rpm (Centrifuge 5417R, Eppendorf, Hamburg) at 4 °C for 
30 min. The cell supernatant was collected and used for further experiments. Protein lysates 
were stored in aliquots at -20 °C. 
 
5.4.2 Protein quantification 
By using the BCA (bicinchoninic acid) Protein Analysis Kit (Pierce, Thermo Fisher), the 
protein concentration of each sample was determined, so equal loading was acquired. The 
analysis was performed in a 96-well plate according to the manufacturer’s protocol. BSA 
was dissolved in lysis buffer in 8 different concentrations (2 mg/ml, 1.5 mg/ml, 1 mg/ml, 
0.75 mg/ml, 0.5 mg/ml, 0.25 mg/ml, 0.125 mg/ml and 0.0625 mg/ml) in order to measure a 
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standard curve. A blank control consisted of lysis buffer only. Afterwards, 25 µl of standards 
and samples were transferred into the wells and 200 µl of the working reagent (50 : 1 mixture 
of solution A and B) were added and mixed thoroughly. Then, the samples were shaken for 
1 min and incubated at 37 °C for 30 min. The solutions’ absorption was measured at 562 nm 
by using a microplate reader (Infinite M200, Tecan) three times. The resulting absorption 
data were analyzed with Microsoft Excel for MAC 2016. Protein concentration of the 
samples was determined by the measured standard curve.  
 
5.4.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) and western blot (WB) analysis 
The nomalized lysate samples (section 5.4.2) were mixed with sample buffer and reducing 
agent (Life Technologies) and heated up to 95 °C for 10 min. After cooling down, samples 
were loaded onto a 4 – 12 % BIS-Tris pre-cast gel (NuPage,Life Technologies) together with 
a Novex Sharp Pre-stained Protein Standard (Life Technologies), as a molecular weight 
marker. The electrophoresis was performed in MOPS (3-(N-morpholino)propanesulfonic 
acid) running buffer (Life Technologies) in a SDS-PAGE Chamber ( Life Technologies) at 
200 V for ~50 min for one gel. 
 
 The proteins, separated by using SDS-PAGE were transferred from the gel to a 
nitrocellulose membrane by wet blotting (X Cell II Blot Module, Life Technologies). The 
transfer by wet blotting system was performed in transfer buffer (Life Technologies) using 
power supply at 30 V for 90 min. After blocking with 3 % (w/v) BSA (Carl Roth) in TBS-
T (50 mM Tris HCl (Carl Roth), 150 mM NaCl (Sigma), 1 % Tween-20 (Carl Roth), pH 
7.5) at RT for 1 h, the nitrocellulose membrane was incubated with primary antibody (Table 
5.4) in a corresponding dilution in TBS-T containing 1 % (w/v) BSA at 4 °C overnight. The 
membrane was washed three times with TBS-T at RT for 10 min and incubated with 
secondary antibody conjugated with HRP enzyme (Table 5.5), diluted in TBS-T containing 
1 % (w/v) BSA, at RT for 1 h. After washing three times with TBS-T for 10 min, the protein 
bands were detected by using luminescent imaging analyzer Amersham Imager 600 (GE 
Healthcare) and ECL Plus Western Blotting Detection Kit (GE Healthcare).  
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Table 5.4 List of primary antibodies. WB = Western blot, IF = Immunofluorescence, CL = Chemical 
luminescence  
Epitope Host Company Cat. No. Application µg/ml 
β-actin mouse Sigma Aldrich A1978 WB 2.5 
Phospho-
SMAD1/SMAD5 
(Ser463, Ser465) 
rabbit Thermo Fisher 700047 WB 5 
rhBMP-6 mouse R&D Systems MAB507 IF, CL 5 
Myosin heavy 
chain (MHC) 
mouse 
Developmental 
Studies 
Hybridoma 
Bank 
MF20 IF, WB 2 
 
 
Table 5.5 List of secondary antibodies. HRP = Horseradish peroxidase, AF 488 = Alexa Fluor 488, 
ms = mouse, rb = rabbit. 
Host & epitope Conjugation Company Cat. No. Application Dilution 
Goat anti-ms IgG HRP Santa Cruz sc-2005 
WB,         
CL 
1:5000, 
1:1000 
Goat anti-rb IgG HRP Santa Cruz Sc-2004 WB 1:1000 
Goat anti-ms IgG 
Alexa Fluor 
488 
Thermo Fisher A-110011 IF 1:500 
 
 
5.4.4 Alkaline phosphatase (ALP) colorimetric assay 
Before seeding onto substrates (section 5.3.3), C2C12 myoblasts were starved for 5 h. Cells 
were either stimulated by iBMP-6 or sBMP-6 (corresponding amount) and cultured for 
6 days in 2 % (w/v) FBS. The medium was refreshed after 3 days. After washing three times 
with PBS, cells were lysed with RIPA buffer (Sigma) without Halt Protease Inhibitor Single-
Use Cocktail and without 5 mM EDTA. After incubation at 4 °C for 30 min, cells were 
detached from the culture well by using a cell scraper. Lysates were separated from cell 
debris by centrifugation in a precooled centrifuge at 14000 rpm at 4 °C for 30 min. The ALP 
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substrate p-nitrophenyl phosphate (pNPP, Sigma) was added to the lysates in a ratio of 2:1. 
Dephosphorylation of pNPP was observed by measuring absorbance at 405 nm in 10 min 
intervals for 60 min using a microplate reader (Infinite M200, Tecan). Data were analyzed 
with Microsoft Excel for MAC 2016. 
 
5.5 Preparation of cells for imaging 
5.5.1 Myosin heavy chain (MHC) staining and imaging 
C2C12 cells were seeded on substrates as described in section 5.3.3. They were cultured on 
the surfaces for 6 days under low serum conditions (2 % FBS). The medium was refreshed 
after 3 days. After removing culture medium and washing three times with PBS, cells were 
fixed with 4 % (w/v) paraformaldehyde (PFA, Sigma) in PBS at RT for 15 min. Samples 
were washed three times with PBS and permeabilized with 0.1 % (v/v) Triton-X 100 (Sigma) 
in PBS at RT for 5 min. Then, cells were washed three times with PBS and blocked with 
1 % (w/v) BSA in PBS for 1 h followed by incubation with primary antibody anti-myosin 
heavy chain (MHC) (see Table 5.4) in PBS with 1 % (w/v) BSA at RT for 1 h. Following 
washing three times with PBS containing 1 % (w/v) BSA, samples were incubated with the 
secondary antibody Alexa Fluor 488 goat anti-mouse IgG (see Table 5.5) in PBS with 1 % 
(w/v) BSA for 1 h at RT. After washing three times with PBS containing 1 % (w/v) BSA, 
samples were mounted with Mowiol (Sigma) supplemented with 1,4-diazabicyclo-[2,2,2]-
octane (DABCO, Merck). The mounting reagent was mixed with DAPI (Sigma) at a final 
concentration 1 µg/ml in order to stain the cell nuclei. Fluorescence images were acquired 
with an upright widefield fluorescence microscope (Leica DM6000B; software LAS AF 
3.2.0.9652, Leica Microsystems CAS). The following air objectives were used: HCX PL 
Apo 10x/0.4, HCX PL Apo 20x/0.7 and HCX PL Apo 40x/0.85 (all Leica).  
 
5.5.2 Image processing, data and statistical analysis  
Data were analyzed and quantified with Microsoft Excel for MAC 2016 and graphics were 
plotted either with Origin 8.5 software (OriginLab Corporation, Northampton, USA) or with 
GraphPad Prism 7.0 for Mac OS (GraphPad Software, La Jolla, USA) and further edited 
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with Microsoft PowerPoint for MAC 2016 or Adobe Illustrator, if not stated otherwise. 
Statistical analysis was done with GraphPad Prism software. Groups were compared using 
t-test with p-values < 0.05 considered as statistically significant. ImageJ (Research Services 
Branch, Image Analysis Software Version 1.51h, NIH, USA) was used to process images. 
Brightness and contrast of microscopy images were adjusted for the presentation. Western 
blot bands and myotubes area were quantified by ImageJ as well116. All plotted data show 
mean values with standard deviations calculated from at least three independent experiments 
(samples in duplicates or triplicates), if not otherwise stated. 
 
5.6 Experiments with multiple myeloma cell line OPM-2 
5.6.1 Cell adhesion on dual functionalized surfaces 
OPM-2 cells were seeded onto dual functionalized surfaces at a density of 1 x 105 per 
surfaces (24 x 24 mm2) in 2 ml RPMI medium supplemented with 10 % (v/v) FBS and 1 % 
(v/v) penicillin/ streptomycin. Since OPM-2 are suspension cells, surfaces were washed with 
PBS in order to detect adherent cells. Before and after washing, images were taken by using 
phase contrast microscope (Axiovert 40C, Zeiss).   
5.6.2 Viability assays 
5.6.2.1 Trypan blue staining 
Multiple myeloma cells OPM-2 were seeded in a 12-well plate at a density of 2 x 105 
cells/well in 1 ml culture medium. The cells were stimulated with either 19 ng BMP-6, 
0.133 µM BMP-6 or 160 µM HCl. After 3 days under standard culture conditions, 1 ml fresh 
medium was added. After 1 day, 2 days, 3 days, 4 days and 7 days, live and dead cells were 
counted by staining with trypan blue (Carl Roth) (9 : 1) using a haemocytometer and phase 
contrast microscope (Axiovert 40C, Zeiss). 
 
5.6.2.2 Water soluble tetrazolium-1 (WST-1) assay 
As described in section 5.3.3, 5 x 104 cells were seeded onto substrates containing iBMP-6 
in 1 ml RPMI and stimulated with either iBMP-6 (19 ng) or sBMP-6 (19ng) and α5β1-
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integrin-selective ligand under standard culture conditions. 1 ml fresh culture medium was 
added after 3 days. After 1day, 3days and 7 days, WST-1 reagent (Roche Diagnostics, 
Mannheim) was added (1 : 10) to the cells, followed by incubation at 37 °C for 30 min. After 
1 min shaking, 100 µl of sample mixture was transferred into a 96-well plate in triplicates. 
The absorbance was measured at 450 nm with Tecan plate reader. By using samples with 
known cell number (8 x 105, 4 x 105, 2 x 105, 1 x 105, 5 x 104, 2.5 x 104, 1.25 x 104) a standard 
curve was prepared for every sampleand data were analyzed with Microsoft Excel for MAC 
2016. 
 
5.6.2.3 Fluorescence-activated cell sorting (FACS) measurement 
Cells were seeded at a density of 5 x 104 cells/surface in 1 ml medium, followed by 
stimulation with either sBMP-6 or sBMP-2. 1 ml fresh culture medium was added after 
3 days. After 5 days and 7 days, suspension cells were scrubbed from the surfaces, 
transferred in Eppendorf tubes (Eppendorf, Hamburg) and washed with PBS. Prior to FACS 
measurement, 1 µl of propidium iodide (Thermo Fisher) in a concentration of 1 mg/ml was 
added to a 300 µl cell suspension in PBS. The fluorescence-activated cell scanning (FACS) 
was performed in cooperation with Dr. Monika Langlotz (Flow Cytometry & FACS Core 
Facility, ZMBH Heidelberg University).  
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6 Results  
The goal of this project was to investigate the influence of the growth factor BMP-6, 
immobilized on different surfaces, on cell signaling and differentiation. A linker system, 
which was established by Dr. Theresa Pohl96 and further developed by Dr. Elisabeth Baha-
Schwab88, was used in this work for covalent immobilization of the growth factor on 
homogeneous gold, gold nanostructured glass and gold nanostructured PEG-DA hydrogel 
surfaces. First, the linker system was characterized by different surface analysis methods 
and biochemical techniques. The bioactivity of the immobilized BMP-6 was proven by 
examining short-term (< 4 h) signaling in BMP-responsive cells. Furthermore, the long-term 
stimulation effects were analyzed by determining cell differentiation. 
 
6.1 Characterization of the linker system for the covalent 
immobilization of BMP-6 
6.1.1 Infrared measurements prove NHS activity 
Glass coverslips were coated with homogeneous layer of gold with a thickness of 50 nm, 
supported by an adhesive chromium layer (thickness of 15 nm), generated by physical vapor 
deposition (section 5.1.1). Afterwards the substrates were functionalized with a self-
assembled monolayer (SAM) of the heterobifunctional linker 11-mercaptoundecanoyl-N-
hydroxysuccinimide ester (MU-NHS). Since the ester is instable against hydrolysis, forming 
the SAM is a critical step in the preparation. In order to prove the successful SAM formation 
on the one hand and the stability of the NHS ester on the other hand, infrared reflection 
absorption spectroscopy (IRAS) was utilized to detect the characteristic groups of the MU-
NHS linker. Figure 6.1 displays the IR spectrum of the reactive groups of interests. The 
methylene asymmetric and symmetric vibrations of the alkane chain can be assigned to the 
weak signals at 2930 cm-1 and at 2850 cm-1. The strong band at 1750 cm-1 can be attributed 
to the three carbonyl groups. The weak signal at 1590 cm-1 and the medium signal at 
1350 cm-1 belong to the N-O asymmetric and symmetric vibrations, respectively. The C-N 
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vibration corresponds to the strong peak at 1250 cm-1. Due to the detection limit of the used 
IR spectrometer, the intensity at wave numbers < 1000 cm-1 could not be determined.  
 
 
 
Figure 6.1 IRAS spectrum and chemical structure of the linker. a) The absorbance of the functional groups 
belonging to the heterobifunctional MU-NHS linker, bond to the gold surface. The absorbance intensity is 
plotted against the wave numbers. b) Chemical structure of MU-NHS. 
 
The results show that all relevant signals could be detected and assigned to the related groups 
of the molecule. Furthermore, it can be concluded that the NHS ester maintains intact. If it 
was deactivated by hydrolyzation, the three signals for nitrogen at 1250 cm-1, 1350 cm-1 and 
1590 cm-1 would not have been detected due to the release of the nitrogen as N-
hydroxysuccinimide (NHS). Moreover, additional signals of the free carboxylic acid were 
not detected, which would be indicated by the O-H (wide peak at 3000 cm-1) in case of ester 
hydrolysis. In summary, it can be stated that the binding of the MU-NHS linker onto the 
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gold surface was successful and the activity of the NHS ester could be preserved during the 
adsorption process.  
 
6.1.2 X-ray photoelectron spectroscopy measurement proves NHS 
stability in aqueous conditions  
Due to the need to perform the linker binding in aqueous conditions for usage on hydrogels 
(see section 6.2.2), the MU-NHS linker was decorated on gold surface, treated in different 
conditions and analyzed by using XPS (section 5.2.1.2). For the comparison of the film 
quality depending on the immersion time the film thickness and the packing density was 
calculated. In addition, the exposure of NHS ester in PBS was tested. 
 
 
Figure 6.2 XPS spectra of the MU-NHS linker on gold surfaces in different conditions. a) Au 4f signal, b) 
C 1s signal, c) N 1s signal, d) S 2p signal. Obtained spectra for distinct atoms are displayed as intensity values, 
plotted against binding energy (BE). Plots: measured signals (…), peak sum (brown), background (orange), 
fitted peaks (magenta, red, cyan). 
 
The XPS spectra of the pristine films exhibit the peaks and doublets characteristic of the 
well-defined SAMs with no traces of contamination or oxidative products. For a reasonable 
comparison between the films the surface, which was incubated for 4 h in DMF, was used 
as a standard. The C 1s, S 2p, and N 1s XPS spectra of the films are presented in Figure 6.2, 
which behave all similarly. 
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The C 1s spectrum of the standard Figure 6.2 exhibits three peaks, which can be tentatively 
assigned into a main component peak at 284.29 eV corresponding to the CH2 chain moiety 
as well as a weaker component peak at ∼285.09 eV associated with the CH2 moiety of the 
five-membered ring, as well as a peak at 288.89 eV which relates to carbonyl component.  
The S 2p XPS spectrum of all spectra exhibits a characteristic S 2p3/2,1/2 doublet at a BE 
position of ∼162.0 eV (S 2p3/2) corresponding to the thiolate species bound to noble metal 
surfaces with no traces of atomic sulfur, disulfide, unbound sulfur, or oxidized species. The 
gold signal was used as internal reference for each sample in order to normalize the area 
under the curve of each signal. The surfaces, which were prepared in 20 min, showed all 
carbon, nitrogen and sulfur signals, which were also detected on the control surface. The 
sample, which was incubated in PBS, displayed also all important signals including the 
nitrogen signal. The normalized intensities of the different conditions are listed in Table 6.1.  
 
Table 6.1 Table shows the intensities of carbon (b), nitrogen (c) and sulfur (d) of the different samples. 
In order to compare the two conditions with the standard sample, the intensities were normalized to the 
corresponding gold signal (a). 
 4 h DMF 4h DMF + 20 min PBS 20 min DMF 
C1 0.170 0.148 0.112 
S2p 0.016 0.013 0.011 
N1s 0.012 0.013 0.007 
 
 
The normalized results for the standard samples were (C1s), (S2p) and (N1s). The results of 
the standard sample and the PBS sample were comparable, especially the nitrogen signal 
was almost identical. This indicates that the ester was not hydrolyzed during 20 min PBS 
incubation. The 20 min sample’s results were lower than the standard with at least 60 % of 
the correlated standard’s signal intensity, which leads to the assumption that a minimum of 
60 % of the surface was covered by MU-NHS-linker within the first 20 min of incubation 
time. According to the spectroscopic data, the presented linker is stable in aqueous 
conditions for more than 20 min. Furthermore, the adsorption time of the linker is rather fast, 
with a more than 60 % coverage of the surface after incubation for 20 min. This means that 
the MU-NHS linker could be used for the fast and effective immobilization on gold 
nanostructured hydrogels in aqueous environment.  
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6.2 Characterization of covalent immobilization of BMP-6 
on surfaces 
In this chapter, the linker system was bound to the three different types of surfaces 
(homogeneously coated gold surface, gold nanostructured glass coverslips and gold 
nanostructured hydrogels) in order to verify the successful BMP-6 immobilization. 
Furthermore, it was investigated, whether BMP-6 remained immobilized on the surface after 
cell contact. 
 
6.2.1 Immobilization of BMP-6 on homogeneous gold 
6.2.1.1 BMP-6 was successfully immobilized to gold  
The following control experiments were carried out to exclude false positive results by 
proving the SAM formation and the non-specific binding affinity of the anti-BMP-6 IgG. 
Then, the successful immobilized BMP-6 was detected on the gold surface by QCM-D and 
by chemiluminescence experiments independently. 
 
Control experiments 
The first control experiment was performed to analyze the SAM formation of the linker in 
aqueous solution and to determine the required time by measuring the frequency change 
during incubation and washing. Comparing normalized frequencies allows a statement about 
SAM formation. The reaction was performed on a quartz crystal of an open module (QCM-
D). For the PEG-DA experiments (section 6.2.3) it is necessary to perform the reaction in 
aqueous solution because other solvents would interact with the hydrogel and damage it. The 
detailed protocol is described in section 5.1.6. Since the MU-NHS linker is poorly soluble 
in water, a 100 mM linker stock solution in DMSO was prepared and diluted with water in 
a ratio 1:100 prior to use. Figure 6.3 shows the frequency and dissipation change during the 
reaction. After calibration with the two buffers PBS (B1) and PBS with 1 M NaCl (B2), the 
MU-NHS linker (1) was added on the gold coated sensors. After approximately 30 min, the 
frequency (blue line) and the dissipation (red line) stopped changing, what indicates the full 
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coverage of the surface with linker molecules. While washing with buffer B2, neither the 
frequency nor the dissipation changed. This means that there is no release of linker molecules 
from the surface. To see the binding to the linker, the sensor was washed with buffer B1. 
Only a small amount of BSA was released from the surface, while the rest remained bond to 
the surface. However, it could not be distinguished whether BSA was bound to the linker or 
physisorbed onto the surface. To sum up, the QCM-D measurements show that the MU-
NHS linker also forms a self-assembled monolayer in aqueous conditions.  
 
 
 
Figure 6.3 The QCM-D diagram shows the successful binding of the linker to the surface and the binding 
of BSA. The frequency is displayed in blue and the dissipation in red. The vertical outliers are caused by the 
exchange of the solutions during the measurement. After addition of MU-NHS linker, the frequency decreased 
and stayed at the same level, while washing with PBS. Blocking with BSA induced a further frequency 
decrease.  
 
In the next control, the affinity of the anti-BMP-6 mouse IgG was investigated by using a 
QCM-D crystal, already decorated with a monolayer of MU-NHS linker in order to exclude 
non-specific binding to the MU-NHS linker. In Figure 6.4 the change of frequency and 
dissipation during the antibody incubation is shown. After calibrating with buffer B1, the 
crystal was incubated with anti-BMP-6 mouse IgG. During the 30 min incubation, both 
frequency and dissipation did not change at all. Afterwards the crystal was washed with PBS. 
There was no change in frequency and dissipation. 
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Figure 6.4 The QCM-D diagram shows no shift in frequency and dissipation indicating the non-
absorption of anti-BMP-6 mouse IgG antibody. The frequency is displayed in blue and the dissipation in 
red. The frequency did not change during the incubation with PBS nor with anti-BMP-6 mouse IgG antibody. 
 
In the second experiment, it could be shown that anti-BMP-6 mouse IgG did not 
unspecifically bind to the surface. It was important to investigate the binding behavior of the 
antibody to exclude false positive results. 
 
Validation of the BMP-6 immobilization on homogeneous gold 
After the control experiments were successfully completed, the immobilization of BMP-6 
was observed by QCM-D (Figure 6.5). The BMP-6 incubation induced a frequency 
decrease, which did not change back to the starting point after rinsing. This indicates that 
BMP-6 bound to the surfaces. In order to validate this result, the immobilized BMP-6 was 
detected via indirect immunochemiluminescence. During the incubation of the primary 
antibody, there was a change in the frequency, which was enhanced after secondary antibody 
incubation. Finally, the QCM-D crystals were revealed in order to detect the immobilized 
BMP-6 with indirect immunochemiluminescnece. As can be seen in Figure 6.5, the crystal 
treated with BMP-6 showed a high and almost homogeneous signal, indicating the presence 
of BMP-6. Moreover, the control surface showed no specific signal. 
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Figure 6.5 The successful immobilization process of BMP-6 is displayed by QCM-D and 
chemiluminescent detection with antibodies. The QCM-D showed the binding of BMP-6 to the linker 
followed by antibody binding (b), while there was no binding of antibodies to the control surface (a). The 
immobilized BMP-6 could be detected by a clear chemiluminescence signal (d). The control surface showed 
only background signal (c). Adapted and modified from Martin et al.98 
 
Summing up, the successful immobilization of BMP-6 could be shown and it was evidenced 
on the surface by direct and indirect detection. 
 
6.2.1.2 BMP-6 binds to the surface through primary amines  
After showing the successful immobilization of BMP-6 to the surfaces, it needed to be 
proven whether the protein binds to the MU-NHS ester through its primary amine group or 
was physisorbed non-specifically. In order to validate the immobilization, the primary amine 
groups were acetylated in order to block it for the NHS ester. Furthermore, the green 
fluorescence protein (GFP) was used as control, because it can be directly detected by 
fluorescence microscope. 
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Validation by QCM-D 
As it could be shown, the MU-NHS linker generated a monolayer. Therefore, the only 
interaction took place between BMP-6 and the linker. This means that the protein could bind 
to the linker in both manners, specifically and non-specifically. By acetylation of the BMP-
6’s primary amines (Ac-BMP-6), specific immobilization was excluded, because the NHS 
ester of the linker cannot react with the protein anylonger. If Ac-BMP-6 still binds to the 
surface, the interaction was unspecific. If Ac-BMP-6 does not bind, the immobilization is 
mediated by the primary amines. 
 
 
 
Figure 6.6 Scheme of the setup for the QCM-D experiment with four different conditions. Sensor 1 and 
Sensor 2 were used as control for the acetylation of the primary amine groups. Sensor 3 proved the 
immobilization through primary amine groups and Sensor 4 was used as control for the acetylation of BMP-6. 
 
In Figure 6.6, the experimental scheme is shown. After incubation with acetylated GFP, the 
BMP-6 could bind to the surface (Sensor 1), whereas it could not bind after incubation with 
normal GFP (Sensor 2). Sensor 1 served as positive and Sensor 2 served as negative control, 
since GFP also contains primary amine groups. In order to prove the specific immobilization, 
Sensor 3 was incubated with acetylated BMP-6, which could not bind, in contrast to the 
GFP, which was incubated afterwards. By incubation with untreated BMP-6, the wafers 
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were completely occupied, so that no GFP was able to bind to the surface (Sensor 4). Sensor 
4 served as control for the acetylation of BMP-6. 
 
 
 
Figure 6.7 The non-binding of Ac-BMP-6 and the successful immobilization of BMP-6 are shown in the 
QCM-D diagram. a) Ac-BMP-6 did not bind to the surfaces, indicated by the return of the frequency back to 
the starting point, in contrast to GFP, which could bind to the surfaces showed by frequency change and 
antibody binding. b) The frequency shift displayed the successful immobilization of BMP-6. Adapted and 
modified from Martin et al.98 
 
The experiment showed that acetylated BMP-6 was not able to bind to the MU-NHS linker 
(Figure 6.7 a), in contrast to the native BMP-6 (Figure 6.7 b). Moreover, GFP could bind 
to the surface after incubation with acetylated BMP-6, but not after incubation with native 
BMP-6.  
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Figure 6.8 QCM-D diagram shows the immobilization of GFP and acetylated GFP. a) The frequency 
decreased slightly during incubation with acetylated GFP and remained below its starting point level after 
washing. After incubation with BMP-6 and washing, the frequency did not change back, but remained at a 
lower point. Then, the frequency decreased further strongly during blocking with BSA. The incubation with 
first anti-BMP-6 antibody did not affect much the frequency, contrary to the incubation with secondary HRP-
conjugated antibody. It changed to a lower level. b) After incubation with GFP, the frequency decreased and 
did not return while washing. The incubation of BMP-6 and the following washing led to a shift of the 
frequency. After blocking, the frequency did not change while incubating with first anti-BMP-6 antibody. But 
while incubating with secondary HRP-conjugated antibody, the frequency reached a lower level than before. 
 
In the second experiment, in which GFP instead of BMP-6 was acetylated, the acetylated 
GFP (Figure 6.8 a) showed a lower binding affinity than the non-acetylated GFP (Figure 
6.8 b). Nevertheless, the affinity was higher than the affinity of acetylated BMP-6. This 
indicates, that the GFP was not completely acetylated, whereas BMP-6 was. 
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Conclusively, the QCM-D results showed that BMP-6 is immobilized to the surface by 
binding through its primary amine groups to the MU-NHS linker. Since the Ac-BMP-6 
showed a significant lower binding affinity to the linker coated surface than the untreated 
BMP-6, a non-specific binding interaction can be excluded as main type of binding. But the 
experiment also showed that GFP was not completely acetylated.  
 
Validation by fluorescence microscopy 
To further validate the results, two QCM-D crystals were treated like Sensor 3 and Sensor 4 
described in Figure 6.6. But instead of incubating with primary and secondary antibody, the 
substrates were removed from the QCM-D and GFP was imaged with fluorescence 
microscope.  
 
 
Figure 6.9 Fluorescence microscopy images of the QCM-D crystals. The fluorescence of GFP is shown in 
green. a) The crystal, decorated with MU-NHS linker, was first incubated with Ac-BMP-6 followed by GFP, 
which could be clearly detected. b) The sensor was incubated with BMP-6 followed by GFP incubation. The 
intensity of the GFP signal was significant lower. 
 
In Figure 6.9, the fluorescence images are shown. The substrate, incubated with acetylated 
BMP-6, showed a strong signal (Figure 6.9 a). This indicates that BMP-6 did not bind to 
the surface and neither reacted with the NHS ester, what allowed GFP to bind to the surface. 
The intensity of the crystal, which was incubated with BMP-6, was significantly lower 
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(Figure 6.9 b). This matches with the previous QCM-D results, in which it was shown that 
BMP-6 occupied the surface, when it could bind to the MU-NHS linker. 
The following experiment aims at investigating BMP-6’s binding ability to different 
surfaces. Therefore, a glass cover slip was treated to give four different areas, namely 
homogeneous gold surface, glass surface, PEG passivated surface and PEG2000 passivated 
nanopatterned surface. GFP served as control. After immobilization of BMP-6, it was 
labeled by using Alexa488 conjugated secondary antibody. In Figure 6.10, fluorescence 
images are shown. Both proteins did not bind to the passivated surface. While BMP-6 and 
GFP binding homogeneously distributed on the passivated nanopatterned surface coated 
with MU-NHS linker, they bound non-specifically to the glass surface. On the gold surface, 
decorated with MU-NHS linker, the fluorescence signal of BMP-6 and GFP were more 
homogeneously distributed, but not as even as on the passivated nanopatterned surface. 
 
 
 
Figure 6.10 Fluorescence images of immobilized BMP-6 and GFP on four different surfaces. The glass 
cover slips, containing four different areas on the surface, were first incubated with the MU-NHS linker 
followed by the immobilization of BMP-6 and GFP, respectively. BMP-6 was detected of Alexa488. The 
fluorescence signal of the proteins showed different distributions on the four areas. Image was adapted and 
modified from Martin et. al.98 
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In conclusion, it could be proven that BMP-6 binds specifically to the MU-NHS ester. 
Furthermore, it does not bind to the PEG2000 passivated surface in a non-specific 
interaction. 
 
6.2.2 Successful immobilization of BMP-6 on gold nanostructured 
surfaces 
This chapter deals with the immobilization of BMP-6 on gold nanostructured surfaces by 
using MU-NHS linked to the gold particles. The inter particle area was passivated with the 
protein repellent PEG2000. 
 
6.2.2.1 Surface characterization by SEM 
The particle distance (Figure 6.11) was varied by employing different block copolymer 
chain lengths resulting in the following particle spacings of (32 ± 8) nm, (63 ± 11) nm and 
(107 ± 21) nm. 
 
 
Figure 6.11 SEM images of gold nanostructured arrays prepared from different diblock copolymer 
solutions on glass. Substrates were imaged with a 50000x (A – C) magnification in order to analyze the inter 
particle distance and order parameter. The order parameter f was calculated to be 0.51 (A), 0.54 (B) and 0.59 
(C), respectively. The mean inter particle distances are indicated above each picture. 
 
6.2.2.2 Detection of immobilized BMP-6 by chemiluminecence immunoassay 
The gold nanostructured substrates with different inter particle distances were prepared as 
described in subsection 5.1.2. The inter particle space was passivated with a protein repellent 
PEG2000 monolayer (section 5.1.4.2). BMP-6 was immobilized on the gold particles 
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D
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through the MU-NHS linker. Since only one BMP-6 homodimer was bound per gold 
nanoparticle, an increased spacing of the gold particles caused a decrease in the amount of 
surface-bound protein. 
Figure 6.12 shows surfaces with a spacing of 32 nm, 63 nm and 107 nm. The immobilized 
BMP-6 was detected with anti-BMP-6 antibody and HRP conjugated secondary antibodies. 
The binding of BMP-6 was visualized via chemiluminescence. 
 
 
 
Figure 6.12 Chemiluminescence detection of iBMP-6 on gold nanostructured surfaces with different 
inter particle spacing. The signal indicated the successful BMP-6 immobilization. The smaller the distance 
between the particles the stronger the signal on the surfaces treated with MU-NHS and BMP-6 (+ BMP-6) 
whereas there was almost no signal or only background detectable on control surfaces (- BMP-6). 
 
The substrates treated with MU-NHS and BMP-6 showed a clear chemiluminescent signal 
(+BMP-6) whereas the negative controls (-BMP-6) displayed almost no signal or 
background noise. Due to the different spacing, the signal intensity decreased (from left to 
right). The increased spacing caused a reduced signal. As the results in section 6.2.1.1 
showed, the BMP-6 did not bind to the PEG layer.  
 
To further investigate the stability of iBMP-6 (5.1.4), C2C12 cells were exposed to the 
surfaces from the top of the cells for 60 min and presence of iBMP-6 was assessed prior and 
after cell contact. The approach is shown in Figure 5.13. BMP-6 was detected using 
chemiluminescence on all surfaces (see Figure 6.13). 
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Figure 6.13 Chemiluminescence detection of iBMP-6 before and after cell stimulation. The surfaces, 
containing iBMP-6 showed a clear signal before and after cell stimulation. Note, the dipping edge (white 
arrow). The substrate with soluble BMP-6 (sBMP-6) and the control surface did not display any signal neither 
before nor after cell contact. Image was adapted and modified from Martin et al.98 
 
iBMP-6 could be detected before as well as after cell stimulation (Figure 6.13). Both 
surfaces showed a strong signal, while on the control surfaces and the surface with sBMP-6 
no BMP-6 was detectable. sBMP-6 was used to prove that BMP-6 bound specifically. The 
dipping edge (see arrow in Figure 6.13) marks the border between the area with and without 
nanoparticles and is due to the preparation.  
Additionally, the stability of the immobilization was verified for longer time periods of 
120 min and 240 min, respectively. The experimental setup was the same as described above. 
The sBMP-6 condition was left out, because it could be already proven that it did not bind 
unspecifically. The surfaces were not parted in order to detect iBMP-6 before cell contact. 
 
 
Figure 6.14 Chemiluminescence detection of iBMP-6 after 120 min and 240 min cell stimulation. The 
surfaces containing iBMP-6 showed high intensities after 120 min and 240 min, while the control surfaces 
without BMP-6 only displayed low background signal. 
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The comparable signal intensity after 120 min and 240 min of the iBMP-6 substrates verified 
the binding stability (Figure 6.14). The high stability of iBMP-6 allowed the usage for 
longer periods of cell stimulation. 
It can be summarized that the density of iBMP-6 on the surface could be controlled by 
varying the inter particle distance. Furthermore, the binding of BMP-6 to the nanopatterned 
via the MU-NHS linker surface was stable for more than 240 min. 
 
6.2.3 BMP-6 binds successfully to gold nanostructured hydrogel  
surfaces 
In this chapter, gold nanostructured hydrogels were prepared and characterized by using 
cryo-SEM and AFM. Afterwards, BMP-6 was immobilized to the gold particles through the 
MU-NHS linker as described earlier (section 5.1.4) and consequently detected by 
chemiluminescence. 
 
6.2.3.1 Nanoparticle transfer to PEG-DA hydrogels   
Gold nanostructured hydrogels were prepared as described in subsection 5.1.6. Prior to the 
analysis by cryo-SEM, the gels were removed from the glass coverslip, frozen in liquid 
nitrogen and coated with a carbon layer. Images were taken from at least three different 
positions. 
 
 
 
Figure 6.15 Cryo-SEM images of nanopatterned hydrogel surfaces after different preparation steps. A) 
The hydrogel surfaces were imaged directly after polymerization and transfer of the gold particles. B) After 
linking the MU-NHS to the gold particles and C) after coupling of BMP-6 to the linker images of the surfaces 
were taken. The differences in intensity were caused by the varying electrostatic charges. 
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The MU-NHS ester was coupled to the gold particles on the hydrogel surface and BMP-6 
was immobilized on the surface as described in subsection 5.1.6.2. Directly after the 
polymerization of the PEG-DA and gold particle transfer, the surfaces were imaged by cryo-
SEM (A). It can be clearly seen that the particle transfer from the glass coverslip to the 
hydrogel worked. Image B shows the surface after connecting the linker to the gold particles. 
The linker binding did not affect the order of the gold particles, since there was no big 
difference between the first images recognizable. However, after the coupling of BMP-6 to 
the NHS linker, the image of the surfaces changed. There were less particles on the surfaces 
with reduced order and increased inter particle distance.  
  
6.2.3.2 Verification of BMP-6 immobilization by chemiluminescence 
immunoassay 
In order the verify the successful immobilization of BMP-6 to the hydrogel surface, BMP-6 
was detected by indirect-chemiluminescence assay Four different conditions were used to 
perform the assay: a gel with nanoparticles, a gel with nanoparticles decorated with MU-
NHS linker, a gel with sBMP-6 and a gel consisting of iBMP-6. 
 
 
 
Figure 6.16 Chemiluminescence detection of BMP-6 on gold nanostructured hydrogels. The gel consisting 
of iBMP-6 showed a clear signal, while the MU-NHS decorated surface showed almost no signal. The surfaces 
with sBMP-6 and no BMP-6, respectively, showed a low background noise. 
 
Figure 6.16 showes that BMP-6 could be successfully immobilized to the hydrogel via the 
MU-NHS (Figure 6.16, right image). The very low signal of the MU-NHS decorated 
hydrogel displayed that the linker passivated the surfaces, so that there was no non-specific 
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binding of the antibodies. This was the case for the untreated surface and the surface 
containing sBMP-6. But even their signals were only a background signal, since they were 
weaker than the iBMP-6 signal. 
 
 
 
Figure 6.17 Chemiluminescence detection of BMP-6 on gold nanostructured hydrogels after 60 min of 
cell contact. The iBMP-6 hydrogel showed a significant higher signal than gels with sBMP-6 or no BMP-6. 
 
In order to test the binding stability, the hydrogels were exposed to C2C12 cells as described 
in subsection 5.3.3 and removed after 60 min. Afterwards, the same assay was used to 
visualize the iBMP-6. Figure 6.17 shows the chemiluminescence images of the hydrogels 
after 60 min cell stimulation. While the control gel and the gel with sBMP-6 showed almost 
no signal, the iBMP-6 surface displayed a significant higher signal. In conclusion, the 
immobilization method for glass coverslips could be successfully transferred to gold 
nanostructured hydrogels. The stability of the binding was also comparable to the substrates 
prepared on glass (see section 6.2.2). 
 
6.3 iBMP-6 maintains its biological activity upon 
immobilization to different surfaces 
In chapter 6.2, the successful immobilization of BMP-6 to different surfaces through its 
primary amine groups could be shown. In this chapter, I focused on validating the biological 
activity of iBMP-6 on the different surfaces. For this reason, short-term and long-term cell 
responses of C2C12 cells to iBMP-6 were investigated. Furthermore, the results were 
compared to sBMP-6 as positive control. 
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6.3.1 Activity of immobilized BMP-6 (iBMP-6) on homogeneous 
gold 
As calculated in section 5.1.3.2, the theoretical amount of BMP-6, which can be immobilized 
on a (24 x 24) mm surface is 460 ng. This amount of BMP-6 was used in soluble form as 
positive control (sBMP-6) in order to compare the results of the iBMP-6. 
 
6.3.1.1 Stimulation of SMAD phosphorylation by iBMP-6 
The phosphorylation of SMAD 1/5, downstream reporters of the BMP-6, signaling pathway 
stimulated by iBMP-6 was analyzed by western blot analysis. For this reason, C2C12 cells 
were incubated either with iBMP-6, sBMP-6 or negative control surface from the top as 
described in section 5.3.3. As shown in Figure 6.18 A, SMAD 1/5 phosphorylation was 
observed after 60 min stimulation with either iBMP-6 or sBMP-6, while SMAD 1/5 
activation is absent in C2C12 cells exposed to negative control samples.  
 
 
 
Figure 6.18 Immobilized BMP-6 maintains its biological activity and induces SMAD signaling. a) C2C12 
cells were stimulated from the top with gold surfaces (control), with gold surface in presence of sBMP-6 and 
iBMP-6 for 60 min. After cell lysis, samples were immunoblotted for phospho-SMAD 1/5 and β-actin. b) 
Phospho-SMAD 1/5 intensities were normalized to β-actin. Error bars represent standard deviation, n = 3, *p 
< 0.05, ***p < 0.0001. Images were adapted and modified from Martin et al.98 
 
The quantification of the Western Blot showed, that the immobilization of BMP-6 did not 
have any significant effect on BMP-6’s short-term activity. The iBMP-6 showed a slightly 
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reduced biological activity like sBMP-6 (Figure 6.18 b). These results validated that iBMP-
6 maintained its biological short-term activity and the ability to trigger early steps in SMAD 
signaling like SMAD 1/5 phosphorylation. 
 
6.3.1.2 Inhibition of myotube formation by BMP-6 
C2C12 cells are known to undergo myogenic differentiation to form myotubes and produce 
characteristic muscle proteins. However, treatment with BMP-6 causes a shift in the 
differentiation pathway from myoblastic to osteoblastic, therefore suppressing the formation 
of myotubes. To investigate the effect of iBMP-6 on myogenesis C2C12 cells were cultured 
for 6 days under differentiation (low serum) conditions. Microscopy studies were performed 
to show myotube formation and to detect myosin heavy chain (MHC).  
 
 
 
Figure 6.19 Fluorescence images show the inhibition of C2C12 myotube formation by iBMP-6 and 
sBMP-6. C2C12 cells were cultured for 6 days under low serum conditions to allow myogenesis. Images show 
myosin heavy chain (MHC IXB) staining of multinucleated myotubes (green) and DAPI nuclei staining (blue). 
The area covered by myosine IXB positive cells was plotted. Error bars indicate the standard deviation, n = 5. 
Images were adapted and modified from Martin et al.98 
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After six days in culture (see section 5.3.3), cells were fixed and stained. The negative 
control showed a high number of myosin IXB positive cells whereas on the surfaces with 
iBMP-6 and sBMP-6 almost no positive cells were found (Figure 6.19). The differences 
between the negative control surfaces and sBMP-6 and iBMP-6 in coverage of myosin IXB 
positive cells can be clearly seen. In summary, the iBMP-6 on homogeneous gold surfaces 
showed stable long-term activity which was comparable to the soluble form, by inhibition 
of myotube formation. 
 
6.3.2 Activity of iBMP-6 on gold nanostructured surfaces 
This chapter deals with nanopatterned surfaces with three different inter particle distances 
(32 nm, 63 nm and 107 nm), containing iBMP-6, which were prepared according to section 
5.1.4. Due to the fact that cells cannot adhere on the passivated nanostructured surfaces, only 
on top stimulation was possible, allowing investigation of the short-term signaling activity 
of iBMP-6, but not the long-term activity. 
 
6.3.2.1 Stimulation of SMAD phosphorylation by iBMP-6 
As calculated in section 5.1.4.2, the amount of BMP-6, which could be immobilized to the 
surfaces, was 19 ng on 32 nm surfaces, 6 ng on 63 nm surfaces and 1 ng on 107 nm surfaces. 
These amounts were used in soluble form as positive control in order to compare them with 
the iBMP-6 results. The experiments were performed as described in section 6.3.1.1. C2C12 
cells were on top stimulated by either iBMP-6, sBMP-6 or negative control surfaces. After 
30 min, 60 min, 120 min and 240 min cells were lysed and the samples were immunoblotted 
for pSMAD 1/5 and β-actin. Figure 6.20 shows the results for different BMP-6 
concentrations. 
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Figure 6.20 Western Blot analysis and quantification of C2C12 cell lysate stimulated by 19 ng (A), 6 ng 
(B) and 1 ng (C) BMP-6. Error bars represent standard error of the mean, n = 5, *p < 0.05. Adapted and 
modified from Martin et al.98 
 
For the highest concentration, 19 ng BMP-6, iBMP-6 showed the highest activity after 
60 min. Then it decreased and started increasing again after 240 min, while sBMP-6 showed 
the highest activity after 30 min and decreased until it reached a stable activity after 120 min 
(A). In comparison, the 6 ng sBMP-6 displayed the maximum after 30 min as well, but it 
started increasing after 240 min (B). Furthermore, the activity progress of the 6 ng iBMP-6 
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was similar to the 19 ng iBMP-6, but even more pronounced. The lowest concentration of 
BMP-6, 1 ng, showed a similar behavior for sBMP-6 as for 19 ng. For iBMP-6, the 
maximum was shifted to 120 min after increasing and then it started decreasing. 
The results displayed that BMP-6 maintained its biological activity also after immobilization 
on nanopatterned surfaces. Furthermore, it could be shown that BMP-6 is still active in very 
low concentration (1 ng) in immobilized and soluble form. Both iBMP-6 and sBMP-6 
showed a different activity. Moreover, the iBMP-6 showed always a higher activity after 
120 min for all concentrations, although it was not significant. 
 
6.4 Dual functionalized surfaces containing BMP-6 and 
adhesive ligand 
In this chapter, gold nanostructured surfaces were dual functionalized in order to immobilize 
adhesive ligands on the PEG layer by click chemistry. This allowed using the substrates for 
long-term stimulations of cells with iBMP-6. For this reason, the effect of iBMP-6 on 
myogenesis and on stimulation of alkaline phosphatase (ALP) activity in C2C12 cells were 
investigated. 
 
6.4.1 Dual functionalization of gold nanostructured glass surfaces 
The dual functionalized surfaces were prepared as described in section 5.1.5 using integrin 
α5β1 selective ligand and cRGD. The adhesive effect was investigated by seeding C2C12 on 
the surfaces. Furthermore, the short-term and long-term activity of iBMP-6 was determined. 
 
6.4.1.1 Validation of ligand’s adhesive effect 
Cells were seeded on surfaces containing integrin α5β1 selective ligand and cRGD ligand, 
respectively, and on non-functionalized surfaces, which were used as negtive control. After 
seeding the C2C12 cells on the surfaces, cell adhesion was observed at different time points 
by using phase contrast microscope. Cells seeded on substrates which were decorated with 
α5β1 specific ligand (+α5β1), started adhering to surface after 30 min (Figure 6.21). After 
90 min, most of the cells were adhered and started to spread, indicated by change of shape. 
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After 18 h, all cells adhered and spread on the surface, while most of the cells on control 
were still round shaped. 
 
 
 
Figure 6.21 C2C12 cells adhesion induced by α5β1 specific ligand. Cells were seeded on substrates and 
phase contrast images were taken after 30 min, 90 min and 18 h. Round cells presented non-adherent cells.  
 
The tri-peptide motif RGD, which is present in many ECM proteins, is established and 
known to induce cell adhesion. For this reason, it was used as comparison for cell adhesion. 
C2C12 cells were seeded on surfaces coated with cRGD ligand. In Figure 6.22, phase 
contrast images can be seen, which show cell adhesion on the substrates containing cRGD 
after 60 min and 240 min. 
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Figure 6.22 C2C12 cells adhered on the surfaces with and without cRGD ligand. Cells were seeded on 
substrates with and without cRGD and phase contarst images were taken after 60 min and 240 min. Adapted 
and modiefied from Martin et al.98  
 
After 60 min, many cells started adhering to the surfaces decorated with cRGD (+ cRGD), 
while cells on the negative control surface were still round (- cRGD). After 240 min almost 
all cells adhered to the cRGD surface in contrast to control. 
In conclusion, it could be shown that the α5β1 selective ligand as well as cRGD induced cell 
adhesion of C2C12 cells.  
 
6.4.1.2 iBMP-6 has a higher biological activity by bottom stimulation 
The biological activity of iBMP-6 on gold nanostructured surface was already proven in 
section 6.3.2. There the cells were stimulated from top by iBMP-6. In this chapter, the 
bottom stimulation was performed as described in section 5.3.3. 
 
Stimulation of SMAD phosphorylation by iBMP-6 
C2C12 cells were seeded on nanostructured surfaces (107 nm) containing cRGD and 1 ng 
iBMP-6. After 60 min and 240 min, cells were lysed to analyze the short-term stimulation 
of the SMAD 1/5 phosphorylation as described previously. After 60 min, iBMP-6 showed 
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the highest activity of on top stimulation (see section 6.3.2.1). Furthermore, it was 
investigated whether iBMP-6 and sBMP-6, respectively, still showed an activity after 
240 min.  
 
 
 
Figure 6.23 iBMP-6 showed a higher biological activity than sBMP-6 in bottom stimulation of SMAD 
1/5 phosphorylation in C2C12 cells. Cells were stimulated with 1 ng BMP-6 in immobilized and soluble 
form. Lysates were immunoblotted for pSMAD 1/5 and β-actin. The pSMAD signals were normalized to β-
actin signal. Error bars represent standard error of the mean, n = 5, *p < 0.05, **p < 0.001. Images were adapted 
and modified from Martin et al.98 
 
Previous experiments (see section 6.3.2.1) could show that already 1 ng BMP-6 was 
sufficient to stimulate C2C12 cells. Therefore, 1 ng BMP-6 was used for the bottom 
stimulation. As it can be seen in Figure 6.23, iBMP-6 showed a very high activity after 
60 min as well as after 240 min. It was significantly higher than the sBMP-6 and control 
samples, respectively.  
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Inhibition of myotube formation by iBMP-6 
In order to investigate the long-term activity in bottom stimulation by iBMP-6, cells were 
seeded on surfaces containing α5β1 selective ligand and cRGD, respectively. Three different 
concentrations of BMP-6 were used: 19 ng, 6 ng and 1 ng. Fluorescence images were taken 
to show myotube formation and to detect myosin heavy chain (MHC subunit IXB). The cells 
were cultured on the surfaces according to section 5.3.3.  
 
In Figure 6.24 A, the fluorescence images of cells seeded on surfaces containing α5β1 
selective ligand and different concentration of BMP-6 are shown. It can be clearly seen that 
iBMP-6 could inhibit myotube formation on all surfaces, while sBMP-6 could only inhibit 
myotube formation with high BMP-6 doses. The quantification of the myosin IXB positive 
cell supports the impression of the images (Figure 6.24 B). 
 
Figure 6.25 shows the same experimental setup but the α5β1 selective ligand was replaced 
by the cRGD ligand. Instead of three different concentrations only two concentrations were 
used to investigate, whether there were any differences in the effect of the highest amount 
(19 ng) and the lowest (1 ng). Besides, the experimental procedures were similar. The results 
were comparable to the α5β1 selective ligand samples. 19 ng of iBMP-6 and sBMP-6 were 
capable to inhibit myotube formation sufficiently. Furthermore, 1 ng of iBMP-6 could still 
trigger the inhibition, while the samples of 1 ng sBMP-6 looked comparable to the control 
surface. The quantification of the coverage matched with these results. 
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Figure 6.24 Fluorescence images show myosine IXB positive C2C12 cells upon iBMP-6 and sBMP-6. a) 
C2C12 cells were seeded on surfaces containing α5β1 selective ligand and stimulated from bottom by 19 ng, 
6 ng and 1 ng BMP-6 for 6 days under low serum conditions to trigger myogenesis. Images show myosin heavy 
chain (MHC subunit IXB) staining of myotubes (green) and DAPI nuclei staining (blue). b) By measuring the 
area, covered by myosine IXB positive cells, quantification was done and the results were plotted. Error bars 
indicate standard deviation, n = 5.  
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Figure 6.25 Fluorescence images show myosine IXB positive C2C12 cells upon iBMP-6 and sBMP-6 on 
cRGD decorated surfaces. a) C2C12 cells were stimulated from bottom by 19 ng and 1 ng BMP-6, 
respectively, under low serum conditions for 6 days to allow myogenesis. Images show myosin heavy chain 
(MHC) staining of multinucleated myotubes (green) and DAPI nuclei staining (blue). b) By measuring the area 
covered by positive cells, and relating to the total area, a quantification was done and the results were plotted 
in percentage. Error bars indicate standard deviation, n = 5. Images were adapted and modified from Martin et 
al.98 
 
Stimulation of alkaline phosphatase (ALP) activity 
The role of ALP as a marker for osteogenic activity has been consistently solidified. To 
determine whether iBMP-6 affects long-term osteogenic differentiation response, alkaline 
phosphatase (ALP) activity of C2C12 cells was measured after a 6-day incubation period. 
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Cells were seeded on surfaces functionalized with α5β1 selective ligand and cRGD ligand, 
respectively.  
ALP activity in lysates of cells cultured on surfaces with α5β1 selective ligand was measured 
as described in section 5.4.4 (Figure 6.26). Lysates of cells cultured on iBMP-6 and sBMP-
6 surfaces (19 ng) showed a higher enzymatic activity than negative control. While the 6 ng 
samples still induced a higher ALP activity than the control, the 1 ng iBMP-6 and sBMP-6 
showed no increase of absorption compared to control sample. 
 
 
 
Figure 6.26 Immobilized BMP-6 stimulated osteogenic differentiation of C2C12 cells on surfaces 
decorated with α5β1 selective ligand. The enzymatic activity of alkaline phosphatase (ALP) indicates 
osteogenic differentiation of C2C12 cells. ALP activity was measured as absorbance at 405 nm. The bar graph 
shows data normalized to corresponding control sample. The error bars indicate the standard deviation, n = 3.   
 
Figure 6.27 shows the results of the experiments, which were performed with cRGD 
functionalized surfaces. Here, BMP-6 was used in two concentrations of 19 ng and 1 ng. The 
absorption of the 19 ng samples were comparable to the corresponding α5β1 selective ligand 
samples. The difference appeared in the 1 ng iBMP-6 sample. It showed a higher ALP 
activity in comparison to the control and sBMP-6 sample with cRGD and was also higher 
than the 1 ng iBMP-6 samples with α5β1 selective ligand. 
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Figure 6.27 Immobilized BMP-6 stimulated also osteogenic differentiation of C2C12 cells on surfaces 
decorated with cRGD ligand even better. The enzymatic activity of alkaline phosphatase (ALP) indicates 
osteogenic differentiation of C2C12 cells. ALP activity was measured as absorbance at 405 nm. The bar graph 
shows data normalized to corresponding control sample. The error bars indicate the standard deviation, n = 3. 
Adapted and modified from Martin et al.98 
 
To summarize the chapter 6.4, it could be shown that iBMP-6 was able to stimulate cells 
more efficiently than sBMP-6 in both short- and long-term basal stimulation. In general, 
differences in the adhesion mediation between α5β1 ligand and cRGD ligand could not be 
noticed. Only in the ALP assay, the 1 ng iBMP-6 with cRGD induced higher ALP activity 
than the corresponding sample on α5β1 selective ligand functionalized surface. 
 
6.5 Applications 
This chapter outlines the medical application of the prepared surfaces. Dr. Anja Seckinger 
and Dr. Dirk Hose (Multiple myeloma division, National Centre for Tumor Diseases (NCT) 
Heidelberg), our cooperation partner, discovered that BMP-6 can be used to induce cell 
death in multiple myeloma cells53. Since BMP-6 had to be used in high concentration when 
applied in soluble form, the aim was to reduce the required amount by immobilizing BMP-
6. The ability for long-term stimulation should help to achieve the desired effect also with 
lower concentration of BMP-6. Therefore, the viability of multiple myeloma OPM-2 cells 
was determined before and after BMP-6 exposure using gold nanostructured glass surfaces 
containing iBMP-6 and α5β1 selective ligand. 
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6.5.1 Validation of ligand’s adhesive effect 
The multiple myeloma cell line OPM-2 are suspension cells, which normally do not adhere 
on surfaces. In order to expose these cells to the immobilized BMP-6, dual functionalized 
surfaces with adhesive ligands were employed to force the cells to adhere. The cells were 
seeded on surfaces decorated with α5β1 selective ligand. Figure 6.28 shows the phase 
contrast images displaying cells adhesion on different surfaces. 
 
 
Figure 6.28 OPM-2 cells adhering on surfaces decorated with α5β1 specific ligand. Cells were seeded on 
four different surfaces: passivated surface, passivated surface with iBMP-6, passivated surface decorated with 
α5β1 specific ligand in presence of sBMP-6 in culture medium and passivated surface with α5β1 specific ligand 
and iBMP-6. Phase contrast images were taken directly after seeding (0 h), after 5 h and after 24 h, respectively. 
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In order to visualize adhesion of the OPM-2 cells to α5β1 specific ligands, the surfaces were 
washed with PBS after 54 h. Before and after washing, images were taken from different 
areas of the surfaces. In Figure 6.29, the differences between surfaces with and without α5β1 
specific ligand can be clearly seen. On surfaces without the ligands the cells were almost 
completely removed by the washing, while on the other ones the cell number did not changed 
much. This indicated the successful adhesion of OPM-2 cells to the ligand. 
 
 
 
Figure 6.29 Washing did not remove OPM-2 cells from surfaces decorated with α5β1. Surfaces were 
washed with PBS in order to remove non-adherent cells. Images were taken before and after washing. 
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In conclusion, it could be shown that the α5β1 selective ligand induced cell adhesion of OPM-
2 cells. Moreover, the adhesion was independent from presence of iBMP-6 and sBMP-6. 
 
6.5.2 Initiation of cell death in myeloma cells 
To investigate the effect of BMP-6 on multiple myeloma cells, BMP-6 was compared to 
BMP-2, which also belongs to the TGF-β superfamily, in order to use it as a control. OPM-
2 cells were treated with BMP-6 or BMP-2, respectively, and cell viability was determined 
after 5 and 7 days by FACS measurement (see section 5.6.2.3). Furthermore, the negative 
control sample (indicated as Ctrl) was not treated. In Figure 6.30, it can be clearly seen that 
BMP-6 decreased the cell viability compared to the negative control sample, while there was 
no detectable effect upon BMP-2 stimulation.  
 
 
 
Figure 6.30 The effect of sBMP-2 and sBMP-6 on OPM-2 cell viability after five and seven days 
stimulation. OPM-2 cells were stimulated with either 1 µg/ml sBMP-2 or 1 µg/ml sBMP-6, which is equal to 
1 µg. After five and seven days, cell viability was determined by FACS. The error bars indicate standard 
deviation, n = 3. 
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After the successful prove of BMP-6 effect on myeloma cells, the maximum amount of 
BMP-6 (19 ng), which could be immobilized on gold nanostructured surfaces (inter particle 
distance of 32 nm), was compared to the concentration (4 µg/ml), which was used by the 
cooperation partner.  
 
Figure 6.31 Determination of the viability and the cell number of OPM-2 cells after stimulation with 
different concentrations of sBMP-6. 200000 OPM-2 cells were treated by sBMP-6 (4 µg and 19 ng) and 
40 µl of 4 mM HCl for seven days. Fresh medium was added after 3 days. A) The cell viability was determined 
by using trypan blue after 1, 2, 3, 4 and 7 days. B) The cell number was assessed by using a haemocytometer. 
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Cell viability was determined by using trypan blue staining and a haemocytometer. 
Furthermore, 40 µl of 4 mM HCl was included as control to avoid false positive results 
coming from the vehicle substance, since BMP-6 was dissolved in 4 mM HCl (section 
5.1.3.2). Fresh culture medium was added after 3 days. sBMP-6 (4 µg) clearly reduced the 
cell viability to 50 % after seven days (Figure 6.31 A), whereas 19 ng sBMP-6 reduced it 
until day 3 and then the viability increased again. The effect of HCl was not significantly 
different to the control, so that it could be neglected. Figure 6.31 B shows the total cell 
number after different days. The doubling time for OPM-2 cells is about 50 – 60 h. If the 
total cell number is 200000 in the beginning, it increases to 3.2 x 106. The cell number of the 
sBMP-6 (4 µg) sample increased more slowly than the other samples. After 7 days, the cell 
number was determined to be 925000. This was a clearly smaller number than the control 
sample (4.1 x 106) and the HCl sample (3.4 x 106). That means 4 µg sBMP-6 significantly 
receded the doubling time. Furthermore, the 19 ng BMP-6 sample showed a smaller cell 
growth than the control samples (3.0 x 106). 
 
Dual functionalized surfaces to induce myeloma cell death 
In the previous experiment, 4 µg of sBMP-6 reduced cell viability and receded the doubling 
time of OPM-2 cells. sBMP-6 in a smaller dose (19 ng) showed also an effect on OPM-2 
cells less than with 4 µg. Therefore, the gold nanostructured surfaces containing α5β1 specific 
ligand and an inter particle distance of 32 nm were used in order to stimulate multiple 
myeloma cells with either iBMP-6. Because of the immobilization, BMP-6 should be 
protected from internalization into the cell, so that the lower amount might be able to have 
an similar effect on OPM-2 cells like 4 µg BMP-6. As negative control, gold nanostructured 
surfaces containing α5β1 specific ligand were used. sBMP-6 was used in the same amount 
(19 ng) like iBMP-6. As it can be seen in Figure 6.32, the iBMP-6 did not show the desired 
effect on OPM-2 cells. Moreover, the results looked as if both BMP-6 substrates would 
stimulate the growth of the cells compared to the control surface.  
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Figure 6.32 The diagram shows the number of living cells after treatment with iBMP-6 and sBMP-6. 
OPM-2 cells were stimulated with 19 ng of iBMP-6 and sBMP-6. After Day 1, Day 3 and Day 7 the number 
of living cells was assessed by using the WST-1 assay. The error bars indicate standard deviation, n = 3. 
 
Conclusively, BMP-6 in high concentration showed a clear effect on multiple myeloma cells 
also compared to BMP-2. However, neither sBMP-6 nor iBMP-6 in low concentration 
showed an effect in reducing cell viability, moreover it seemed as if BMP-6 stimulated the 
cell growth. 
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7 Discussion and Outlook 
The objective of this work was to engineer dual functionalized glass surfaces and PEG-DA 
hydrogels exhibiting both covalently coupled BMP-6 and adhesive ligands in order to 
investigate the effects of immobilized BMP-6 on BMP-mediated signaling and osteogenic 
differentiation in C2C12 cells. Furthermore, this approach was adapted to determine the 
effects of these engineered substrates on the proliferation of multiple myeloma cells. 
For this purpose, a covalent immobilization strategy for BMP-6 was chosen in order to avoid 
uncontrolled release and diffusion of the growth factor. By using gold nanostructured 
surfaces, it was possible to control the amount and density of immobilized BMP-6. With this 
it was possible to reduce the amount of BMP-6 by a factor of 600. Recently, the successful 
immobilization of BMP-2 was shown using alkane thiols containing an NHS moiety as 
linker (Pohl et al.70 and Schwab et. al.72).  
 
7.1 Characterization of the linker system and adhesive 
ligands  
Anderson et al.117-119 proposed the N-hydroxysuccinimide (NHS) for the synthesis of active 
esters more than 50 years ago. In theory, NHS esters are relatively stable and can be stored 
for months under water-free conditions. However, the main reason for a suboptimal 
conjugation yield is the premature hydrolysis of the NHS ester120. The heterobifunctional 
linker 11-mercaptoundecanoyl-N-hydroxysuccinimide (MU-NHS), which was used to 
immobilize BMP-6 to the surface, maintained its activity after SAM formation on gold 
surfaces in dry DMF, as was proven by IR spectroscopy. The detected signals correlated 
with documented signals in literature121. The region in the spectra between 1200 cm-1 and 
400 cm-1, which is also called fingerprint region, was not further analyzed. In this range, 
many vibrations do not show an ideal behavior and display a shift by more than 100 wave 
numbers122. Due to electronic effects in the molecule, most of the structure and bend 
vibrancies are affected by this shift and the spectrum can have several hundred absorption 
bands. Therefore, the analysis of this region is challenging and not exact.  
7 Discussion and Outlook 
92 
Due to the need of using aqueous solvents for the immobilization of BMP-6 on gold 
nanostructured PEG-DA hydrogels, the NHS ester’s stability in aqueous solvent could be 
determined by XPS (see section 6.1.2). In recent studies, it was shown that the stability 
against hydrolysis was reduced by increasing the pH 123. In pH conditions below 7.5, the 
ester showed its highest stability124. This is in agreement with the results, which were 
obtained in an almost neutral pH of 6.8. Furthermore, the required time for SAM formation 
of the MU-NHS linker was determined to be 20 min, what is even quicker than the results 
published in literature. The adsorption time of thiol alkane depends on its nature. Long chain 
alkanethiols (> C5) form well-ordered SAM during 2-24 h. In comparison, short chain 
alkanethiols (< C6) need to be incubated for at least 24 h125. The order of the SAM is 
increased by longer incubation time. In conclusion, the NHS linker can be immobilized in 
20 min through SAM formation in aqueous solvents without losing its activity.   
 
Cell adhesion promoted by adhesive ligands 
The most important receptors for cell adhesion and adhesion mediated cell signaling are 
represented by the integrin family75. These proteins play an important role in the interaction 
between cells and the extracellular matrix (ECM) proteins. Due to their function, they are 
bidirectional and heterodimeric cell surface receptors73. Although it was possible to perform 
long-term (up to seven days) studies with surfaces, bearing gold and SAM of MU-NHS 
linkers coupled with BMP-6, cell adhesion to the surfaces was rather unspecific and guided 
by deposition of cell own matrix. This can mediate further signaling modulation of SMAD 
pathway (see section 3.1.2), as also reported for other systems65, 126-127. In this work, the 
integrin selective ligand α5β182 and cyclic RGD were used to functionalize the PEG 
passivation layer between the gold nanoparticles by click-chemistry83 to create an adhesive 
background while preserving the setup for the covalent immobilization of BMP-6. 
Successful cell adhesion and spreading of C2C12 cells could be shown on surfaces coated 
with cyclic RGD and α5β1 selective ligands. Cell adhesion already started after 30 min and 
60 min, respectively. These results match with the times of cell adhesion promoted by 
adhesive ligands which are published in literature75, 128-129. This approach accelerates cell 
adhesion and allows bottom stimulation by immobilized BMP-6.  
Furthermore, the functionalization of the surfaces with α5β1 selective ligand successfully 
promoted the adhesion of the OPM-2 suspension cells. In multiple myeloma, the bone 
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marrow is the preferred microenvironment for the proliferation and differentiation of the 
malignant plasma cells which rarely disseminate out of the bone marrow. ECM components 
within this microenvironment may play an important role in the specific adhesion and 
retention of the myeloma cells. Kibler et al.130 published the strong expression of β1 integrin 
subunit in OPM-2 cells. This explains the strong cell adhesion to the α5β1 selective ligand 
coated surface.   
 
7.2 Stiffness of artificial biomaterials 
One of the major challenges in engineering of synthetic tissues for implantation is the 
development of a soft transition between the artificial and native tissue, especially in 
musculoskeletal tissues, where the function of the tissue comprises the production or 
transmission of forces131. The most crucial point is the stiffness of the artificial material, 
which influences cell adhesion and cell signaling132.  
 
7.2.1 Incorporation of adhesive ligand influences the hydrogels’ 
stiffness 
PEG-DA hydrogels containing gold nanostructured surfaces were prepared as described in 
section 5.1.6.3 and the Young’s modulus was determined by AFM (Figure 7.1).  
 
 
Figure 7.1 Young’s modulus of the PEG-DA hydrogels with different cRGD concentration. The stiffness 
was measured by AFM on five different positions with ten repetitions each. The error bars show the standard 
deviation, n = 50. 
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The control sample, which did not contain any cRGD, had a stiffness of 70 kPa, while the 
stiffness of the PEG-DA hydrogels was reduced by increasing the concentration of 
incorporated cRGD, following a linear decrease except the highest concentration of cRGD. 
However, the stiffness dramatically decreased in gels containing 10 % (w/w) cRGD to 4 kPa, 
whereas gels with 1 % (w/w) cRGD had a stiffness of 54 kPa.  
 
 
 
Figure 7.2 C2C12 cell adhesion on PEG-DA hydrogels containing cRGD. Cells were seeded on substrates 
with cRGD with concentrations ranging from 0.0 % to 10 % (w/w) related to the PEG-DA concentration. 
Images were taken after 30 min, 90 min, 150 min, 240 min and 24 h. Round cells presented non-adherent cells. 
 
Paxton et al.133 showed the influence of incorporated hydroxyapatite and acrylated GRGDS 
on the stiffness of PEG-DA hydrogels. They observed that the stiffness was reduced from 
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15 kPa to 5 kPa by incorporation of acrylated GRGDS, while the stiffness was increased to 
32 kPa by incorporating hydroxyapatite. This is in accordance with the obtained results. 
Phase contrast images clearly show the effect of the cRGD concentration on cell adhesion 
(Figure 7.2). Most of the C2C12 cells started adhering already after 90 min and were 
completely adherent on 10 % (w/w) cRGD substrate after 240 min. In comparison, a few 
cells adhered on 1 % (w/w) cRGD after 90 min, while on 0.1 % and control substrate no 
adhesion could be observed at all. After 24 h on the cRGD functionalized hydrogels cells 
adhered and spread on the surface, while on control hydrogels no cell adhesion and cell 
spreading could be observed. 
 
Taken together, by incorporation of cRGD into the hydrogel, the stiffness of the hydrogels 
was decreased by increasing the cRGD concentration. Furthermore, it was possible to easily 
introduce a cell adhesion mediated background, which allowed to investigate long-term 
stimulation of cells. 
 
7.2.2 Influence of stiffness on cell signaling in C2C12 cells 
Many cells alter their proliferation and differentiation state depending on the mechanical 
stiffness of the substrate, e.g. the ECM134-135. In order to investigate the influence of the 
material’s stiffness on BMP-mediated cell signaling in long- and short-term BMP-6 
stimulation of C2C12 cells, gold nanostructured hydrogels with an interparticle distance of 
32 nm, containing iBMP-6, were prepared according to section 5.1.6. cRGDN3 was 
incorporated into PEG-DA hydrogels in concentrations of 10 %, 1 % and 0.1 % (w/w) (see 
section 7.2.1), respectively. After successful establishment of an adhesive background (see 
Figure 7.2), the capability of iBMP-6 to stimulate C2C12 cells from bottom in short- (up to 
4 h) and long-term (up to 7 days) was investigated.  
 
Inhibition of myotube formation and stimulation of ALP activity by iBMP-6 
Here, preliminary results of long-term stimulation of C2C12 cells by iBMP-6 are shown in 
(Figure 7.3). On the one hand, iBMP-6 (19 ng) was able to inhibit myotube formation as 
well as sBMP-6 (19 ng) compared to control (gold nanostructured hydrogel surface without 
BMP-6) on hydrogel (A and B), which contained 0.1 % (w/w) cRGD resulting in a stiffness 
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of 65 kPa (see Figure 7.1). These first results were comparable to the results obtained with 
glass surfaces (see section 6.3.1.2 and 6.4.1.2), which had a higher stiffness. This is in 
accordance with Engler et al.136, who prepared polyacrylamide hydrogels with a stiffness 
ranging from 2 kPa to 27 kPa and observed myotube formation using glass surfaces as 
control. They demonstrated that the optimal elastic modulus for myotube formation is 
12 kPa, what matches stiffness of muscle tissue. Moreover, their gels with the highest 
stiffness (27 kPa) showed comparable results like glass surfaces. Furthermore, they observed 
that the myotube’s morphology is affected by the stiffness. They were more round shaped 
than elongated compared to the myotube formed on glass surfaces. This observation matches 
with the results from Ren et al.137 who showed that stiffness modulates deeply adhesion, 
proliferation and differentiation. They concluded that each of these processes has its own 
stiffness requirement. 
 
Figure 7.3 Immobilized BMP-6 supressed myotube formation, but did not stimulate osteogenic 
differentiation of C2C12 cells. A) C2C12 cells were seeded on indicated surfaces and cultured for 6 days 
under low serum conditions to allow myotube formation. Images show myosin heavy chain (myosin IXB) 
staining of multinucleated myotubes (green) and DAPI nuclei staining (blue). Image magnification 20x. B) By 
measuring the area, covered by positive cells, and relating to the total area, a quantification was done and the 
results were plotted in percentage. Error bars indicate standard deviation, n = 5 repetitions of images. C) The 
enzymatic activity of alkaline phosphatase (ALP) indicates osteogenic differentiation of C2C12 cells. ALP 
activity was determined via absorbance at 405 nm. Bar graph shows data acquired after 60 min reaction. The 
error bars indicate standard deviation, n = 3. 
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On the other hand, there was no observable difference in ALP activity between iBMP-6 and 
sBMP-6 stimulation compared to control sample. C2C12 cells were cultured on PEG-DA 
hydrogels, which contained 1 % cRGD resulting in a stiffness of 54 kPa (see Figure 7.1). In 
comparison with results in section 6.4.1.2, it seemed as if iBMP-6 and sBMP-6 could not 
stimulate the ALP activity and that the osteogenic differentiation was influenced by the 
stiffness of the biomaterial. This is in contrast to Gilde et al.138, who showed that the ALP 
activity is dependent in a manner that the activity is increased by decreasing the substrate’s 
stiffness. They prepared different surfaces with a stiffness ranging from 100 kPa to 400 kPa. 
However, the here used range of stiffness was different than to Gilde et al. Therefore, the 
influence of the stiffness on ALP activity was different, what complicates a comparison. 
 
SMAD 1/5 phosphorylation by iBMP-6 
 
 
Figure 7.4 Western Blot analysis and quantification of C2C12 cells stimulated by 19 ng iBMP-6 and 
sBMP-6 on hydrogels with and without cRGD. After 90 min, cells were lysed and samples were 
immunoblotted for phospho-SMAD 1/5 and β-actin. iBMP-6 on gold nanostructured glass surfacse co-
functionalized with cRGD was used as positive control. 
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In this experiment, two different kinds of PEG-DA hydrogels were used. One contained 
cRGD in a concentration of 10 % resulting in a stiffness of 4 kPa and one was without cRGD 
resulting in a stiffness of 74 kPa. The preliminary results, shown in Figure 7.4, indicated 
that iBMP-6 on both hydrogels was not able to stimulate the SMAD1/5 phosphorylation 
successfully compared to control surface, while sBMP-6 on both hydrogels stimulated the 
phosphorylation of SMAD 1/5. iBMP-6 on glass surface showed a clear signal for pSMAD 
1/5. 
In summary, the presented preliminary results showed the cells’ differentiation dependence 
on the material’s stiffness. Results need to be further investigated to prove the reproducibility 
and to further study the relation between differentiation and surface stiffness. 
 
7.3 Immobilization of growth factors 
For the first time, it was shown in this work that BMP-6 was covalently immobilized via the 
heterobifunctional linker mercaptoundecanoyl-N-hydroxysuccinimide ester (MU-NHS) to 
gold nanostructured glass surfaces and hydrogel. Furthermore, the covalent immobilization 
of BMP-6 was combined with the integrin α5β1 selective ligand and cRGD which promoted 
cell adhesion resulting in the dual functionalization of surfaces. In this group, the covalent 
immobilization of BMP-2 a related growth factor via the MU-NHS linker as either self-
assembled monolayer or bound to the gold nanoparticles have been successfully 
established70-72. Tabisz et al. recently showed the site-directed immobilization of BMP-2139. 
The protein was immobilized to neutravidin-agarose beads by modifying recombinant 
human BMP-2 site-specifically and using copper-catalyzed azide-alkyne cycloaddition 
(CuAAC) to bind it directly or via a short biotin-PEG linker. This method allows the 
immobilization of BMP-2 in a specific orientation in order to produce fully defined 
osteogenic surfaces. Although the strategy used in this work does not allow a precise control 
over the orientation of the protein, it enables to specifically immobilize the growth factor to 
the surface without further modifications of the molecule and control the density. This 
simplifies the preparation and avoids side and cross reaction between the active sites of the 
protein.  
The currently available approaches of immobilization like encapsulation or adsorption to the 
scaffold require very high concentrations (100 µg/ml) of growth factors compared to the low 
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concentration in human blood140-141. This can cause an initial burst release phenomena142, 
leading to a release of BMP2 from such scaffolds into extracellular environment where it 
affects surrounding tissues causing bone overgrowth, osteolysis, and inflammation143. To 
avoid these problems, Meinel et al.144 presented a silk fibroin construct for controlled 
delivery of entrapped proteins or small molecule drugs. However, a controlled release into 
the human blood system only allows for growth factor stimulation for a specific time period. 
By using the covalent immobilization strategy, as presented in this work, undesired side 
reactions in the body can be circumvented. Additionally, the verified stability of the bond 
between the linker and the amine residues of the protein even after cell contact enables long-
term stimulation of cells possible by using this approach. The effective immobilization of 
BMP-6 on surfaces, showing that the growth factor is still active even after a longer period 
of time, has not been reported so far. 
Nevertheless, it should be noted that iBMP-6 was not homogeneously distributed on the 
surfaces, what can be clearly seen (refer to Figure 6.12 and Figure 6.13). As a consequence, 
the produced substrates could never be equal, but varied in a small range resulting in a 
fluctuation of the obtained results. A quantitative comparison between the iBMP-6 and 
sBMP-6 is not entirely correct, but it indicates a tendency in the short- and long-term 
stimulation ability.  
 
The phosphorylation kinetics and levels in cells, which were stimulated from top by iBMP-
6 did not differ much from the ones exposed to sBMP-6 (refer to Figure 6.20). In 
comparison, cells adhering to cRGD surfaces stimulated by iBMP-6 showed significant 
faster and higher phosphorylation kinetics (stimulation over 4 h) levels than the cells 
exposed to sBMP-6. This indicated that the combination of immobilized BMP-6 and the 
adhesive ligand cRGD increased in the SMAD1/5 phosphorylation levels. Another 
advantage in comparison to other systems is the strongly reduced amount of BMP-6, which 
was used to obtain cellular response. With the introduced platform for growth factor 
immobilization combined with adhesive ligands, the required amount for short-term 
stimulation was 1 ng, which is equal to 0.033 nM. This is approximately 600-fold smaller 
than the typical amount of 20 nM, which is used in standard in vitro assays.  
Furthermore, it could be shown that the BMP-6 capability of myotube suppression was not 
dependent in the mode of presentation without adhesive ligands, but dependent when it was 
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presented with the adhesive ligands cRGD and the α5β1 selective ligand. iBMP-6 showed a 
higher efficiency than sBMP-6 even in very low amounts (1 ng). While the adhesive ligands 
did not have an influence on myotube suppression, cRGD seemed to influence positively the 
stimulation of ALP by iBMP-6 (1 ng, see Figure 6.27). In literature, it was published that 
BMP-6 induces high ALP activity already at low concentration and after 5 days32, 41. Since 
the amount, which can be immobilized to the surfaces, is limited, BMP-6 combining with 
adhesive ligands is a potent candidate for immobilization approaches in order to induce 
ontogenetic differentiation. The low required amount of BMP-6 also reduces the costs what 
makes it even more attractive. 
 
On top stimulation vs. bottom stimulation 
Differences between the on top and from bottom stimulation of C2C12 could be shown. The 
bottom stimulation with iBMP-6 showed higher phosphorylation activity than the on top 
stimulation. This can be caused by the fact that the space between the cells and iBMP-6 is 
filled with a few µl of culture medium, when cells are stimulated from the top. Therefore, 
the distance between cells and iBMP-6 cannot be controlled and this can cause non-contact 
of cells and iBMP-6. However, when cells are bottom stimulated, they sit and grow directly 
in contact with iBMP-6. On the one hand, this leads to total stimulation and not only partly 
stimulation. On the other hand, it also accelerates the stimulation compared to the soluble 
delivery of BMP-6. Therefore, the bottom stimulation is the preferred way of stimulation 
which can be performed with the dual functionalized surfaces. 
 
The here presented approach allows the local and controlled delivery of BMP-6 in order to 
minimize adverse responses to make this technique applicable for therapeutic usage. 
Additionally, it reduces the required amount drastically, therefore optimizing costs and 
reducing side effects.  
 
7.4 Initiation of cell death in multiple myeloma cells 
One goal of this project was the medical application of the here presented approach. It is 
known that BMP-6 shows effects on multiple myeloma cells. Seckinger et al.53 published 
the inhibition of proliferation in multiple myeloma cell lines. Their experiments proved that 
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BMP-6 showed its positive effect on myeloma cell death initiation in rather high 
concentrations (> 5.3 nM), when applied in soluble form. Moreover, 133 nM BMP-6 
decreased cell viability to about 60 % and reduced the total cell number to 10 % compared 
to control after three days. However, it seemed that lower concentrations of BMP-6 on the 
contrary even stimulated the proliferation of multiple myeloma cells. This was also observed 
in experiments results shown in this work (compare Figure 6.31). The samples, treated with 
high concentrated BMP-6 (133 nM), showed 80 % less cells than the control after seven 
days. Furthermore, the cell viability was less than 60 %. During the first three days, there 
was no significant difference in cell viability detectable between 0.6 nM and 133 nM BMP-
6. On later time points, the low dose did not show a significant effect on cell viability 
anymore. One reason could be the internalization and degradation of BMP-6 by the myeloma 
cells, so that it was depleted from the medium. Nevertheless, the proliferation was 
successfully reduced by the high dose, while the low dose did not show a significant effect 
on cell proliferation compared to control sample. As mentioned previously, high doses of 
grow factors in general and BMP-6 in special in human body can cause lot of side effects, 
which are supported by the systemic treatment. The here presented approach was used to 
reduce the required amount for cell death induction and to replace the systemic treatment 
with a local one. The fact that multiple myeloma cells are suspension cells makes the dual 
functionalized surfaces presenting BMP-6 and adhesive ligands as the method of choice. 
Besides, Kim et al.145 published that BMP-6 is present in the kidney and potent to inhibit 
growth in human renal carcinoma cell lines. In other cancers such as prostate146-147 or breast 
cancer148 BMP-6 is supposed to promote tumor progression and development of metastasis. 
These results showed that BMP-6 should be applied in rather low doses to reduce and avoid 
side effects, respectively. In order to avoid BMP-6 internalization and to increase the effect 
on cell viability in multiple myeloma cells, iBMP-6 on the dual functionalized approach with 
α5β1 selective ligand. The expression of integrin β1 in multiple myeloma cells is known in 
literature149-151 and was employed in this work to successfully promote cell adhesion via the 
α5β1 selective ligand (compare Figure 6.28), whereas it was not possible to promote cell 
adhesion of multiple myeloma cells by using cRGD. The living cell number was determined 
after three and seven days, respectively (see Figure 6.32), whereby iBMP-6 and sBMP-6 
did not comprise different results. However, both samples showed a higher number of living 
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cells than the control sample. The approach did not show the desired effect, means the low 
dose of BMP-6 seemed to be not insufficient to affect in the immobilized form either. 
Until now, it is not known how BMP-6 induces cell death and inhibits proliferation in 
multiple myeloma. This needs to be further investigated in order to optimize the conditions 
of the BMP-6 application. Furthermore, the approach presented in this work can be further 
optimized in regards to the delivery form of BMP-6.  
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8 Summary and Conclusion 
In this work, a novel platform copresenting growth factors, namely BMP-6, with cell 
adhesion promoting cues such as the α5β1 integrin selective ligand or the integrin binding 
RGD peptide was presented. This setup was used to investigate the independence of growth 
factor cell signaling and integrin-mediated cell adhesion. BMP-6 was covalently 
immobilized to prevent internalization and therefore achieve their sustained presentation to 
cells. Moreover, on this approach, based on surface nanopatterning, BMP-6 and either of the 
two integrin selective ligands cRGD and α5β1 selective ligand were immobilized, while 
maintaining their biological activity. By addressing the lysine residues and the N-terminus 
of the growth factor, BMP-6 was covalently immobilized to gold nanoparticles using MU-
NHS linker. The adhesive ligands containing azide moisty were coupled to the PEG-alkyne 
by applying CuAAC click reaction. The presentation of factors using these platforms could 
be controlled independently by tuning the nanoparticle distances and the number of 
functional groups on the PEG to vary growth factor surface density and optimize cell 
attachment to the surface. This approach provides for the first time the presentation of active 
BMP-6 in small and defined amount on surfaces, while achieving controlled spatial 
resolution in combination with adhesive ligands. I showed that co-presentation of BMP-6 
and either of the two adhesive ligands promoted SMAD 1/5 phosphorylation and osteogenic 
differentiation of mouse myoblastoma cells, at amounts as low as 1 ng, whereas addition of 
soluble BMP-6 in equal amounts was significantly less effective. I proved that a local control 
of ligands’ density is crucial for modulating cell response. A potential medical application 
of the presented approach dealing with the initiation of cell death in multiple myeloma cells 
by iBMP-6 was also performed.  
In future studies, the underlying molecular mechanisms are addressed, in particular 
regarding the regulation of lineage commitment and differentiation of cells to be able to 
make our approach suitable for clinical applications, e.g. scaffold functionalization and more 
in general tissue engineering. Furthermore, the transfer of the here presented approach on 
PEG based hydrogels allows the preparation of a platform, which enables the investigation 
of long-term cell signaling studies with controlled and covalently immobilized growth 
factors in combination with adhesive ligands. This setup is not limited to BMP-6 in particular 
and BMPs in general, but is applicable for any growth factors containing primary amine 
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groups, which can be addressed by the MU-NHS linker. Furthermore, other groups of the 
protein can be utilized by exchanging the NHS ester with appropriate reactive groups, e.g. 
nickel-nitrilotriacetic acid (NTA) addressing a polyhistidine-tag (His-tag) or a maleimide 
targeting cysteine residue. This makes the presented technique a versatile tool, since the dual 
functionalized linker only needs to contain a thiol group to bind to the gold nanoparticles. 
This allows for the investigation of short- and long-term signaling pathways stimulated by 
growth factors. This work can help to study cell pathways and interactions in order to 
understand the underlying mechanisms of various diseases paving the way towards new 
drugs and therapeutical treatments.  
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9 Appendix 
9.1 Chemiluminescence detection of BMP-6 and GFP after 
QCM-D observation 
While the surface treated with MU-NHS and BMP-6 showed a strong and intensive signal, 
the control surface without BMP-6 treatment displayed almost no signal. This confirmed the 
QCM-D results in the previous section and proved the immobilization of BMP-6 to the 
homogeneous gold surface. 
 
 
 
Figure 9.1 Chemiluminescence detection and quantification of BMP-6 and GFP on QCM-D crystals. The 
QCM-D sensors, which were first treated witch acetylated protein (sensor 1 and sensor 3), showed a higher 
signal than the other two sensors (sensor 2 and sensor 4). These results were supported by the intensity 
quantification supports. 
 
The final chemiluminescence detection of BMP-6 and GFP on the QCM-D sensors (Figure 
9.1) proved the results from the QCM-D experiment. The acetylated proteins bound weaker 
to the surfaces coated with MU-NHS linker than the untreated proteins. 
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9.2 BMP-6 detection on homogeneous gold surface by 
chemiluminescence 
In order to validate the results and prove the reproducibility, glass coverslips were coated 
with homogeneous gold, supported by an adhesive chromium layer, generated by physical 
vapor deposition. Afterwards the substrates were functionalized with a SAM of MU-NHS 
ester, followed by immobilization of BMP-6 to the surface. Then, the surfaces were blocked 
with BSA and incubated with primary anti-BMP-6 mouse IgG antibody and secondary anti-
mouse IgG antibody conjugated with HRP. The detection of BMP-6 was performed with 
luminescent imaging analyzer using ECL detection kit as described in section 5.2.2.1. 
Figure 9.2 shows the successful immobilization of BMP-6 on gold substrates. 
 
 
 
Figure 9.2 Chemiluminescence detection of BMP-6 on gold substrates. Surface bound BMP-6 was detected 
with indirect immunochemiluminescence. As control, a surface, which was not incubated with BMP-6, was 
used. Image was adapted and modified from Martin et al.98 
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13 Abbreviations 
 
°C degree Celsius 
A amplitude 
Ac-BMP-6 acetylated BMP-6 
ActR activin receptor 
AFM atomic force microscopy 
ALK activin receptor-like kinase 
ALP alkaline phosphatase 
APS ammonium persulfate 
APTES (3-aminopropyl)triethoxysilane 
BCA bicinchominic acid 
BCMN block-copolymer micellar nanolithography 
BDNF brain-derived neurotrophic factor 
BISC BMP-induced sgnaling complex 
BMP bone/body morphogenetic protein 
BMPR BMP receptor 
BMSC bone mesenchymal stem cell 
BRC bone remodeling compartments 
BRI BMP receptor I 
BRII BMP receptor II 
BSA bovine serum albumin 
BSE backscattered electrons 
c concentration 
CBD collagen-binding domains 
cDNA complementary DNA 
cFN cellular fibronectin 
CL chemical luminescence 
cm centimeter 
CMC critical micelle concentration 
co-SMAD common mediator SMAD 
cRGD cyclic RGD 
Ctrl control 
CuAAC copper(I)-catalyzed azide alkyne cycloaddition 
DABCO 1,4-diazabicyclo-[2,2,2]-octane 
DNA deoxyribonucleic acid 
DAPI 4',6-diamidino-2-phenylindole 
DMEM Dulbecco’s modified Eagle's minimal essential medium 
DMF dimethyl formamide 
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DMSO dimethyl sulfoxide 
Dvr-6 decapentaplegic vegetal related 
ECM extracellular matrix 
EDTA ethylenediaminetetraacetic acid 
eV electron volt 
f frequency 
FACS fluorescence-activated cell sorting 
FBS fetal bovine serum 
FGF-1 fibroblast growth factor 1 
g gram 
GAGs glycosaminoglycans 
GDF growth differentiation factor 
GF growth factor 
GFP green fluorescent protein 
h hour 
HRP horseradish peroxidase 
HS heparan sulfate 
Hz Hertz 
iBMP-6 immobilized BMP-6 
IF immunofluorescence 
IgG immunoglobulin G 
IR infrared 
IRRAS infrared reflection absorption spectroscopy 
kPa kilopascal 
l  liter 
L  loading rate 
M molecular concentration 
m meter 
MAD mother against decapentaplegic 
mbar millibar 
MeOH methanol 
MHC myosin heavy chain 
min minute 
MOPS 3-(N-morpholino)propanesulfonic acid 
mRNA messenger RNA 
MSC mesenchymal stem cell 
MU-NHS 11-mercaptoundecanoyl-N-hydroxysuccinimide 
MΩ megaohm 
n number 
N Newton 
NCT National Centre of Tumor Diseases 
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NGFβ nerve growth factor β 
NHS N-hydroxysuccinimide 
nm nanometer 
nM nanomolar 
OP osteogenic protein 
p pressure 
p. a. pro analysi / analytical grade 
P2VP poly(2-vinylpyridine) 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
PDMS poly(dimethyl siloxane) 
PE primary electron 
PEG polyethylene glycol 
PEG-DA PEG diacrylate 
PES photoemission spectroscopy 
PFA paraformaldehyde 
PFC preformed complex 
pNPP p-nitrophenyl phosphate 
PS polystyrene 
PS-b-P2VP poly(styrene-b-2-vinylpyridine) 
pSMAD phosphorylated SMAD 
PTFE polytetrafluoroethylene 
QCM-D quartz crystal microbalance with dissipation 
R-SMAD receptor-redulated SMAD 
RGD arginine, glyacine, aspartic acid 
RIPA buffer radioimmunoprecipitation assay buffer 
RNA ribonucleic acid 
rpm rounds per minute 
RPMI Roswell Park Memorial Institute medium 
RT room temperature 
s second 
SAM self-assembled monolayer 
sBMP-6 soluble BMP-6 
SDS sodium dodecyl sulfate 
SE secondary electron 
SEM scanning electron microscope/microscopy 
Sma small body size 
SPR surface plasmon resonance 
TBS-T tris-buffered saline with Tween 20 
TEMED tetramethylethylenediamine 
TGF-β transforming growth factor β 
Tris tris(hydroxymethyl)aminomethane 
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V volume 
VEGF-A vascular endothelial growth factor A 
Vgr-1 vegetal related 1 
W watt 
w weight 
WB western blot 
WST-1 water soluble tetrazolium-1 
XPS X-ray photoelectron spectroscopy 
θ phase angle 
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